ACS Publications. Most Trusted. Most Cited. Most Read
Discovery of Peptidic Siderophore Degradation by Screening Natural Product Profiles in Marine-Derived Bacterial Mono- and Cocultures
My Activity
  • Open Access
Article

Discovery of Peptidic Siderophore Degradation by Screening Natural Product Profiles in Marine-Derived Bacterial Mono- and Cocultures
Click to copy article linkArticle link copied!

  • Mónica Monge-Loría
    Mónica Monge-Loría
    School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
  • Weimao Zhong
    Weimao Zhong
    School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
    More by Weimao Zhong
  • Nadine H. Abrahamse
    Nadine H. Abrahamse
    School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
  • Stephen Hartter
    Stephen Hartter
    Georgia Aquarium, 225 Baker St. NW, Atlanta, Georgia 30313, United States
  • Neha Garg*
    Neha Garg
    School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
    Center for Microbial Dynamics and Infection, Georgia Institute of Technology, 315 Ferst Drive, Atlanta, Georgia 30332, United States
    *Email: [email protected]
    More by Neha Garg
Open PDFSupporting Information (1)

Biochemistry

Cite this: Biochemistry 2025, 64, 3, 634–654
Click to copy citationCitation copied!
https://doi.org/10.1021/acs.biochem.4c00706
Published January 14, 2025

Copyright © 2025 The Authors. Published by American Chemical Society. This publication is licensed under

CC-BY 4.0 .

Abstract

Click to copy section linkSection link copied!

Coral reefs are hotspots of marine biodiversity, which results in the synthesis of a wide variety of compounds with unique molecular scaffolds, and bioactivities, rendering reefs an ecosystem of interest. The chemodiversity stems from the intricate relationships between inhabitants of the reef, as the chemistry produced partakes in intra- and interspecies communication, settlement, nutrient acquisition, and defense. However, the coral reefs are declining at an unprecedented rate due to climate change, pollution, and increased incidence of pathogenic diseases. Among pathogens, Vibrio spp. bacteria are key players resulting in high mortality. Thus, alternative strategies such as application of beneficial bacteria isolated from disease-resilient species are being explored to lower the burden of pathogenic species. Here, we apply coculturing of a coral-derived pathogenic species of Vibrio and beneficial bacteria and leverage recent advancements in untargeted metabolomics to discover engineerable beneficial traits. By chasing chemical change in coculture, we report Microbulbifer spp.-mediated degradation of amphibactins, produced by Vibrio spp. bacteria to sequester iron. Additional biochemical experiments revealed that the degradation occurs in the peptide backbone and requires the enzyme fraction of Microbulbifer. A reduction in iron affinity is expected due to the loss of one Fe(III) binding moiety. Therefore, we hypothesize that this degradation shapes community behaviors as it pertains to iron acquisition, a limiting nutrient in the marine environment, and survival. Furthermore, Vibrio sp. bacteria suppressed natural product synthesis by beneficial bacteria. Understanding biochemical mechanisms behind these interactions will enable engineering probiotic bacteria capable of lowering pathogenic burdens during heat waves and incidence of disease.

This publication is licensed under

CC-BY 4.0 .
  • cc licence
  • by licence
Copyright © 2025 The Authors. Published by American Chemical Society

Special Issue

Published as part of Biochemistry special issue “A Tribute to Christopher T. Walsh”.

Introduction

Click to copy section linkSection link copied!

The ocean hosts an immense diversity of organisms, particularly coral reefs, which support 25% of all marine life, despite only covering 0.2% of the ocean’s area. (1) This organismal diversity translates into the biosynthesis of a wide variety of compounds with unique molecular scaffolds, ecological roles, and bioactivities. (2−4) Bioactive compounds from marine sources are especially useful, as their secretion into the ocean results in dilution necessitating a high potency to elicit a physiological response. (5) At present, 13 marine-derived drugs have been approved by the Food and Drug Administration (FDA) in the United States, and 32 are at different clinical trial stages, (6) demonstrating the chemical potential circumscribed to these environments. Interestingly, around a third of these compounds have been isolated from soft-bodied, sessile organisms such as corals and sponges. These characteristics are evolutionary drivers for biosynthetic pathways that produce compounds used for defense, as an advantage against competitors and as predation mechanisms. (7) Apart from producing these advantageous secondary metabolites, marine macroorganisms have also developed the ability to obtain such compounds from microbes. (7) In order to do so, they form intricate associations and symbiotic relationships with microbes such as bacteria, fungi, viruses and dinoflagellates; a system collectively referred to as the holobiont. (8,9) In fact, a myriad of marine natural products previously thought to be produced by eukaryotic organisms have later proven to be of bacterial origin. (10−12) These complex relationships modulate the macroorganism’s health as well as their response to environmental stressors; (13−17) therefore, these communities are dynamic in order to select for the fittest holobiont. (18)
Globally, coral reefs are in a precarious state due to increased water temperature, increased incidence of disease, overfishing, hypoxia, and ocean acidification resulting in negative consequences for marine biodiversity, coastal erosion, drug discovery avenues, and human livelihood. Consequently, coral cover has declined by half since the 1950s. (19) Thus, concentrated efforts are being taken to preserve and restore coral reefs by breeding resilient corals. (20) Another approach that has seen a recent surge is the use of beneficial bacteria as probiotics to prevent opportunistic infections by pathogens which accelerate tissue damage when temperatures increase during summer. (21−24) Indeed, the dynamic behavior of coral microbiomes has been linked to resilience of corals against stressors. (25) The coral probiotic hypothesis proposes that by changing their microbial communities, corals are able to develop resistance to pathogens significantly faster than through mutation and natural selection alone. (18) Evidence of such defensive symbioses has been observed in sponges, corals, tunicates, mollusks, crustaceans, as well as terrestrial invertebrates and vertebrates. (26,27) Probiotic bacteria can confer resistance to the host by competitively excluding pathogens, producing antibiotic compounds or a combination of both. (28−30) Delgadillo-Ordoñez et al. have demonstrated the microbial community shifts in coral reefs upon introduction of probiotic bacteria, alongside the decrease of pathogenic Vibrio. (31) Moreover, Ushijima et al. have shown the use of probiotic bacteria as prophylactic treatment against stony coral tissue loss disease (SCTLD), to slow disease progression. (21) Additional probiotic strains have been explored to treat SCTLD, (23) as it has rapidly spread across the coast of Florida and into the Caribbean since its outbreak in 2014, affecting over 20 species of coral and causing the mortality of 30% of corals in Florida. (32)
The opportunistic pathogen, Vibrio coralliilyticus, is associated with disease outbreaks in the marine environment affecting various organisms including corals, oysters, and various fish species (33−37) and is resistant to different classes of antibiotics such as tetracyclines and β-lactams. (38−41) Although antibiotic application as a topical paste has been successful in coral diseases, (42,43) it does not present a long-term solution and also raises concern of spreading antibiotic resistance from marine to terrestrial environments. Furthermore, pathogenic species such as V. coralliilyticus are part of normal microbiota of corals, but their abundance has been shown to increase during stressors such as increased temperatures during summer and exacerbation of disease acuteness through coinfections. (44) Thus, introducing beneficial bacteria isolated from the marine environment serves as a useful and safe approach to reduce the pathogenic burden. The coral reef ecosystem presents a source of a very rich microbial consortium whose components interact in complex ways and microbial repositories are being created and exploited to identify beneficial traits. (23,24) To leverage the coral probiotic hypothesis in the search for beneficial bacterial traits, we isolated and obtained several coral or sponge-derived microbes and cocultured them with a coral-derived strain of V. coralliilyticus (Cn52-H1), capable of producing andrimid, toxins, and additional virulence factors. (39) Furthermore, we cultured strains that we have shown as prolific producers of natural products, previously isolated from corals.
In the marine environment, literature surveys have identified Actinobacteria, Firmicutes and Proteobacteria as the main phyla linked to antimicrobial activity and natural product biosynthesis (4) among marine bacteria. Proteobacteria are the most abundant and diverse phylum (45) in the ocean, collectively constituting over 50% of bacteria. Proteobacteria are additionally one of the major protease-producing phyla. (46−50) This phylum includes the genus Pseudoalteromonas, which is known to devote up to 15% of its genome to secondary metabolite production. (51) This genomic distribution is on par with known prolific secondary metabolite producers such as Streptomyces. (52) Apart from pigments such as violacein, and pyomelanin, Pseudoalteromonas produce bioactive compounds including thiomarinol, macrolactins and bromoalterochromides and bioactive pigments such as prodigiosin. (4,53) Another genus belonging to this phylum is Microbulbifer, a genus that has been recognized for its enzymatic capabilities (54−58) and that has recently sparked interest due to its natural product potential. Secondary metabolites such as bulbiferates, (59) bulbiferamides (60,61) and pseudobilbiferamides (62) have been described, however, the gap between identified natural products and the number of BGCs in their genomes exhibits the potential for natural product discovery from Microbulbifer. (63) Thus, we ensured that representatives of the genera Pseudoalteromonas and Microbulbifer were included as coculture partners with V. coralliilyticus Cn52-H1. Using comparative untargeted metabolomics, coupled with the introduction of a pathogenic coculture partner, we aimed to identify potential beneficial traits of marine-derived bacteria against the pathogen. Using this approach, we discovered the ability of Microbulbifer spp. bacteria to enzymatically degrade a peptidic natural product, amphibactin, a siderophore produced by V. coralliilyticus Cn52-H1 reducing its affinity for iron. The biological function of amphibactins is to acquire iron from the surrounding environment, which is a scarce commodity for microbes in dilute ocean environments and is essential for microbial growth. (64,65) Notably, amphibactins were found to be one of the most abundant siderophores in the open ocean highlighting its ecological importance. (65) We observe that the degradation of amphibactin is carried out in the peptide backbone by multiple strains, which is the first report of such a hydrolysis of peptidic siderophores further enhancing the ecological implication of our finding. In retaliation to the presence of beneficial bacteria, V. coralliilyticus Cn52-H1 suppressed natural product biosynthesis by the beneficial bacteria. Thus, our work highlights complex interplay of biochemical interactions between marine derived pathogenic and beneficial bacteria.

Results and Discussion

Click to copy section linkSection link copied!

Comparative Metabolomics of Bacterial Mono- and Cocultures with V. coralliilyticus Cn52-H1

A total of 210 bacterial strains either isolated from Acropora cervicornis coral (119 isolates, sourced from Georgia Aquarium, Figure 1A) or sourced from previous isolations (23,66) were cocultured with V. coralliilyticus Cn52-H1, previously isolated from healthy corals. (23) This Vibrio isolate was selected as a coculture partner since we previously showed production of andrimid by this strain, (23) a known secondary metabolite elicitor (67) and due to the implicated role of V. coralliilyticus as a member of pathogenic consortia in the marine environment. The bacterial strains that altered colony morphology of V. coralliilyticus Cn52-H1 were prioritized for liquid culturing (Figure 1B and Table 1). Three extraction methods were performed to capture a wider breadth of metabolites (Figure 1C): liquid–liquid extraction (LLE), solid phase extraction (SPE), and solid–liquid extraction (SLE). Metabolomics data on these extracts were acquired via ultrahigh-performance liquid chromatography (UHPLC) coupled to high-resolution mass spectrometry (MS) in the positive ionization mode using data-dependent acquisition. Chromatographic peaks were extracted using MZmine2 (68) which provides a feature list consisting of m/z, retention time, and area under the chromatographic peak for each metabolite feature. The metabolites detected in blank and media controls were subtracted from this output resulting in a total of 5349 high quality metabolite features along with a consensus MS2 spectra for each feature. This data was further analyzed to compare the metabolite profiles of mono- and cocultures as summarized in Figure 1C and described in detail below.

Figure 1

Figure 1. Bacterial isolation and metabolomics workflow. (A) Bacterial isolation from coral mucus, tissue, and the remaining skeleton was performed on six different culture media. Morphologically distinct colonies were isolated and restreaked to ensure purity. (B) Prioritized isolates’ phenotype in mono- and coculture with V. coralliilyticus Cn52-H1. (C) Prioritized strains were cocultured with V. coralliilyticus Cn52-H1, metabolites were extracted using liquid–liquid extraction (LLE), solid phase extraction (SPE), and solid–liquid extraction (SLE). The extracts were analyzed using UPLC-MS and the data was processed for downstream analysis using a suite of cheminformatics tools for compound annotation.

Table 1. Strains Prioritized for Coculture with V. coralliilyticus Cn52-H1
straingenusoriginreferences
Cnat2–18.1PseudoalteromonasCoral; Colpophyllia natans, Atlantic Ocean (23)
DL2H-2.2PseudoalteromonasCoral; Diploria labyrinthiformis, Atlantic Ocean (23)
Ofav2–7PhotobacteriumCoral; Orbicella faveolata, Atlantic Ocean (23)
AC-K1-M-019PseudoalteromonasCoral; A. cervicornis, Georgia Aquariumthis work
CNSA002MicrobulbiferSponge; Smenospongia aurea, Atlantic Ocean (66)
VASA001BacillusSponge; S. aurea, Atlantic Ocean (66)
The feature list and consensus MS2 spectra was first used to generate a feature-based molecular network (FBMN) in the global natural products social molecular networking (GNPS) (69) platform, which was visualized in Cytoscape (70) (Figures 2A and S1). A node in the network represents a unique m/z and chromatographic retention time (referred to as metabolite feature in this manuscript). The network is generated by quantifying MS2 spectral similarity and consists of either singleton nodes (MS2 spectrum having no similarity with other MS2 spectra in the data set) or several clusters of connected nodes (similar MS2 spectra). Similarity in chemical structures result in similar MS2 spectra, hence, the connected nodes represent structurally related molecules. In this network, 538 nodes (10.1% of total) were detected exclusively in extracts of monocultures, 76 nodes (1.5%) in extracts of cocultures, and 4733 (88.5%) were shared across all culture extracts (Figure 2B). An UpSet plot was generated in the Intervene platform (71) to visualize the distribution of the 76 features detected across different coculture extracts (Figure 2C). Notably, the cocultures between V. coralliilyticus Cn52-H1 and Pseudoalteromonas sp. Cnat2–18.1, Microbulbifer sp. CNSA002, and Pseudoalteromonas sp. AC-K1-M-019 had the highest number of unique features, with 24, 22, and 19 unique features, respectively. The 15 of 22 features detected in coculture of Microbulbifer sp. CNSA002 clustered together representing structurally related compounds that are exclusively detected in coculture. Thus, this coculture combination was further prioritized for analysis including principal component analysis (PCA, Figure 2D) and heat map generated using hierarchical cluster analysis (HCA, Figure S2). The PCA plot revealed a clear separation between mono- and coculture, with principal components PC1 and PC2 accounting for 74% of variance. The heatmap supports the observation that the metabolome of each group is distinct and reveals more features that display variable detection between mono- and coculture extracts.

Figure 2

Figure 2. Metabolome profiling of bacterial mono- and cocultures. (A) FBMN showcasing a subset of features that were annotated in this study and their representative chemical structures. The amphibactin cluster and a cluster of unknown metabolites detected in coculture with Microbulbifer sp. CNSA0002 and sharing the MS2LDA motif 531 with the amphibactin cluster are highlighted with a green circle. (B) A Venn diagram representation of the number of features detected across different culture conditions. (C) An UpSet plot is used to show the distribution of 76 features unique to cocultures. (D) PCA plot of untargeted metabolomics data acquired on extracts of V. coralliilyticus Cn52-H1 monoculture, Microbulbifer sp. CNSA002 monoculture and their coculture.

Annotation of Features Variably Detected in CNSA002 Coculture

Several approaches were applied to identify the metabolite features, production of which was observed to be variable in the PCA, HCA (Table S1) and UpSet plot analysis (Table S2). First, the FBMN was queried to identify whether MS2 spectral matching with the GNPS library resulted in a match. These matches were further analyzed for accuracy of annotation. Second, the MS2 spectra of metabolite features with no spectral matches in the GNPS library were analyzed using a suite of cheminformatics tools including Sirius, (72) CANOPUS (73) with CSI:FingerID, (72) and MS2LDA (74) (see Methods Section) and multiple natural product databases such as the Natural Product Atlas, (75) and MarinLit (76) were manually searched. Several natural products were annotated using this pipeline (Table S3), relevance of which is described in the following subsections. However, the cluster of 15 nodes of interest detected exclusively in coculture of V. coralliilyticus Cn52-H1 and Microbulbifer sp. CNSA002 (orange nodes highlighted with a green circle, Figure 2A) had no spectral matches in the GNPS spectral library and no reasonable annotations were obtained by manual searching of the spectral or compound databases. Thus, we resorted to in silico methods for annotation before the isolation and structural characterization via NMR was attempted. The MS2LDA analysis, an unsupervised substructure discovery method, which outputs a set of common fragment ions and neutral losses in the MS2 spectra was applied. The features of interest contained the substructure motif 531, also present in the nodes annotated as amphibactins. The characteristic peak at 191.102 m/z, and its related fragments (Figure 3A,B), lead us to hypothesize the presence of an N-acetyl-N-hydroxy-ornithine amino acid as a substructure in these nodes of interest. This modified, noncanonical amino acid is ubiquitous in siderophores as the hydroxamate moiety is a strong iron chelator. (77) The comparison of MS2 spectra of the unknown feature at m/z 617.411 and apo-amphibactin F further supported this observation (Figure 3B). We searched for an analyte corresponding to m/z of Fe(III)-amphibactin complex and Fe(III) complex of feature with m/z 617.411, but only observed Fe(III)-bound amphibactin (Figure 3C,E). Interestingly, concomitant with the exclusive detection of the unannotated features in the coculture, amphibactins themselves were not detected in coculture (Figures 3E, and 4A). This observation further substantiates the developing theory that these features likely originate from Microbulbifer sp. CNSA002 mediated degradation of amphibactins (Figure 3D). Additionally, since no features from Microbulbifer sp. CNSA002 monoculture were linked to this MS2LDA motif, we concluded that this biotransformation occurs on the amphibactin produced by V. coralliilyticus Cn52-H1, which was further verified by isolation and structural characterization.

Figure 3

Figure 3. Amphibactin degradation by Microbulbifer sp. CNSA002. (A) MS2LDA motif 531, annotated as containing N-acetyl-N-hydroxy-ornithine. (B) Spectral comparison of amphibactin F and unknown feature with m/z 617.411 produced only in coculture. (C) MS2 mirror plot of amphibactin F and Fe(III)-amphibactin F. No Fe(III)-bound complex of m/z 617.411 was observed. (D) Amphibactin F, produced by V. coralliilyticus Cn52-H1 is degraded in the presence of Microbulbifer sp. CNSA002 cell-free supernatant producing compound 1, structurally elucidated through NMR (Table S4 and Figures S4–S12). Iron-binding hydroxamate moieties are circled. (E) Boxplots of the relative abundances of amphibactin F and its degradation product in their apo- and complex form in monoculture and coculture. (F) Petri plate showing iron chelating activity of purified compound 1 using O-CAS agar assay.

Figure 4

Figure 4. Detection of amphibactins and their degradation products. (A) Boxplots of the relative abundances of amphibactin F (876.529 m/z) and its degradation product (617.412 m/z) in monoculture of V. coralliilyticus Cn52-H1, Microbulbifer sp. CNSA002, their coculture, and Cn52-H1 culture in the presence of cell-free supernatant of CNSA002. (B) Boxplots of relative abundances of degraded amphibactin F in V. coralliilyticus Cn52-H1 cell-free supernatant alone, after boiling, and in the presence of flow through or retentate of an ultrafiltration experiment with either a 3 kDa or 10 kDa membrane. (C) Boxplots of amphibactins and (D) their degradation products in V. coralliilyticus Cn52-H1 monoculture and its coculture with Microbulbifer sp. CNSA002. (E) New amphibactin analogs indirectly identified through their degradation products in Microbulbifer sp. CNSA002 and V. coralliilyticus Cn52-H1 cocultures. The position of double bond was not determined and is putatively placed (shown with dashed line). (F) Boxplots of the relative abundances of amphibactin F and its degradation product in V. coralliilyticus Cn52-H1 monoculture and in coculture with several Microbulbifer sp. strains.

The V. coralliilyticus Cn52-H1 and Microbulbifer sp. CNSA002 coculture was extracted and fractionated using SPE, followed by HPLC (Figure S3). The fractions were analyzed by liquid chromatography–mass spectrometry (LC–MS) to determine the composition of each fraction. The fraction with the highest purity was characterized through one-dimensional (1D) and two-dimensional (2D) NMR validating the proposed structure of unknown feature at m/z 617.411, referred to as compound 1 from hereon (Figures S4–S12 and Table S4). Notably, the difference between this structure and amphibactin F lies in the absence of a serine and an N-acetyl-N-hydroxy-ornithine unit (Figure 3D). The loss of these two amino acids are commensurate with a Δm/z of 259.112 between the amphibactin and the respective amphibactin degradation product (Figure 5B). In this way, we were able to assign the putative chemical structures to the 15 nodes exclusively present in coculture and the corresponding parent amphibactin molecule (Figures S13, S14 and Table 2). This assignment was additionally confirmed through the compounds’ fragmentation patterns (Figures S13 and S14).

Figure 5

Figure 5. Detection of hydroxamate siderophores and ferrisiderophores in the presence of Microbulbifer sp. CNSA002. (A) Boxplot of the relative abundances of desferrioxamine E and ferrioxamine E (601.356 m/z and 654.267 m/z respectively) in Pseudoalteromonas sp. Cnat2–18.1 and Microbulbifer sp. CNSA002 mono- and coculture. (B) Boxplot of the relative abundances of desferrichrome and ferrichrome (688.326 m/z and 741.237 m/z respectively) when supplemented in a Microbulbifer sp. CNSA002 culture and controls. (C) Representative structures of peptidic hydroxamate siderophores: aquachelin, marinobactin, and moanachelin.

Table 2. Degraded Amphibactins Detected in V. coralliilyticus Cn52-H1 and Microbulbifer sp. CNSA002 Coculture
nametheoretical m/z [M + H]+experimental m/z [M + H]+error (ppm)corresponding amphibactintheoretical m/z [M + H]+acyl tailreferences
degraded amphibactin D573.386573.3860Amphibactin D832.5026C14:0 (78)
degraded amphibactin V587.401587.4010Amphibactin V846.5183C15:0 (79)
degraded amphibactin B589.381589.3810Amphibactin B848.4975C14:0;3-OH (78)
degraded amphibactin E599.401599.4021.7Amphibactin E858.5183C16:1 (78)
degraded amphibactin H601.417601.4170Amphibactin H860.5339C16:0 (78)
degraded amphibactin C615.396615.3971.6Amphibactin C874.5132C16:1;3-OH (78)
degraded amphibactin F617.412617.4120Amphibactin F876.5288C16:0;3-OH (78)
degraded amphibactin I627.433627.4330Amphibactin I886.5496C18:1 (78)
degraded amphibactin G643.428643.4271.6Amphibactin G902.5445C18:1;3-OH (78)
degraded amphibactin analog 1575.365575.3650Analog 1834.4819C13:0;3-OHthis work
degraded amphibactin analog 2587.365587.3661.7Analog 2846.4819C14:1a;3-OHthis work
degraded amphibactin analog 3597.386597.3860Analog 3856.5026C16:2athis work
degraded amphibactin analog 4603.396603.3971.7Analog 4862.5132C15:0;3-OHthis work
degraded amphibactin analog 5629.412629.4120Analog 5888.5284C17:1a;3-OHthis work
degraded amphibactin analog 6631.428631.4271.6Analog 6890.5437C17:0;3-OHthis work
degraded amphibactin analog 7645.443645.4430Analog 7904.5599C18:0;3-OHthis work
a

Position of double bond was not determined.

To test for the ability of compound 1 to bind Fe(III), we performed a modified chrome azurol S (CAS) assay (O-CAS assay (80)). The positive control, desferrioxamine mesylate, and compound 1 showed a color change from blue to orange (Figure 3F). This observation suggests that the degraded amphibactin can bind iron. This observation is expected as compound 1 is still a tetradentate hydroxamate ligand. However, a decrease in binding affinity is expected due to the loss of a hydroxamate moiety. Furthermore, we did not detect the Fe-bound form of compound 1 while Fe(III)-bound amphibactin was detected (Figure 3C, Δm/z of 52.9115, [M + Fe-2H]+ adduct), suggesting that other siderophores or proteins produced by Microbulbifer sp. can steal iron from the degraded amphibactin form. Indeed, Microbulbifer sp. does have the ability to acquire iron as shown by the O-CAS assay (Figure S15). The purported lower iron affinity can be explained by Fe(III)’s preference for octahedral geometry, maximizing iron affinity when ligands are hexadentate. (81) However, tetra- and bidentate siderophores can also form a complex with Fe(III) and support bacterial growth, but have lower binding affinity. (81−83) Examples of these siderophores include 2,3-dihydroxybenzoylglycine, amonabactins, rhodotorulic acid, alcaligin and bisucaberin. (82,84−86) Tetradentate, dihydroxamate siderophores have also been found to form different Fe(III) complexes at different pH, for instance Fe2L3 complexes (where LH2 represents the ligand), in order to complete the coordination for iron. (87) This complex form including singly or doubly charged adducts of the amphibactin degradation products were manually searched in the data set and were also not detected under our experimental conditions further supporting that Microbulbifer degrades amphibactin to gain competitive advantage for iron acquisition.

Enzymatic Degradation of Amphibactins and New Amphibactin Analogs

One drawback of single-vessel cocultures is the difficulty in assigning the biological source of the molecule to either bacteria. To overcome this challenge and validate that Microbulbifer sp. is required for the detection of compound 1, we cultured V. coralliilyticus Cn52-H1 in the presence of cell-free supernatant of Microbulbifer sp. CNSA002. Cell-free supernatant controls of monocultures were incubated with filtered artificial seawater (FASW) alongside and treated in the same manner. Metabolites were extracted and data were acquired following the workflow in Figure 1C. The amphibactin degradation products were not detected in the cell-free supernatant of V. coralliilyticus Cn52-H1, which indicated that the degradation is not a time-, temperature- or light-dependent transformation (Figures 4A and S16). Additionally, no change in pH was observed upon coculture. The amphibactin degradation products were detected in coculture (Figure 4A, Cn52-H1 + CNSA002). To explore if the degradation of amphibactin is enzymatic, we boiled both the cell-free supernatant and the lysed cell pellet of CNSA002 and incubated it with V. coralliilyticus Cn52-H1 cell-free supernatant containing amphibactins. No degradation was observed after boiling (Figures 4B and S17). Additionally, we also fractionated the Microbulbifer sp. CNSA002 supernatant using 3 and 10 kDa ultracentrifugation filters to separate small molecules from macromolecules. The degradation was observed only with the retentate of either filter and no degradation was observed with the flow through of either filter (Figures 4B and S17). Therefore, we propose that the amphibactin degradation is carried out by a protease produced by Microbulbifer sp. CNSA002.
All analogs of amphibactin are degraded by Microbulbifer sp. CNSA002 (Figure 4C,D), and the degraded compounds are generally detected at a higher intensity than the corresponding amphibactins. Some amphibactins (D, G, H, I, V, analog 5, 6 and 7) were not detected in the V. coralliilyticus Cn52-H1 monoculture (Figure 4C), but concurrent with their increased production in coculture, their degradation products were detected in coculture with Microbulbifer sp. CNSA002 (Figure 4D). This observation, in conjunction with FBMN annotation propagation and MS2 analysis, allowed for the indirect determination of seven amphibactin analogs that had not been previously reported (Figure 4E). These analogs differ in acyl chain length, six of the seven contain a hydroxylation, and one of the analogs is doubly saturated (Table 2). The membrane partitioning of amphibactins is previously reported to be higher for longer chain acyl-siderophores when compared with shorter chain, unsaturated, and hydroxylated fatty acids. (88) Additionally, coculturing often results in shifts in membrane composition and fatty acid profiles of microorganisms. Thus, variable fatty acid precursors may be available in coculture for acylation of the amphibactin headgroup. We surveyed five additional Microbulbifer sp. strains from our library to determine whether amphibactin degradation is a conserved trait across different marine Microbulbifer sp. bacteria. Among the tested bacteria, the strains MLAF003 and ZMAC003 degraded amphibactin, whereas MKSA007, VAAF005, and VASA003 did not. However, genomic analysis of the amphibactin-degrading and nondegrading strains did not yield a candidate protease following this pattern, suggesting that some Microbulbifer sp. are nondegrading due to the enzyme either not being present or not being expressed under the conditions tested (Figure 4F).
Iron, being an essential trace nutrient, is acquired by microorganisms from the external environment as Fe(III) via siderophores, especially in marine environments where iron availability is limited. Thus, high-affinity siderophore production and iron acquisition lie at the heart of mutualistic and competitive interactions between organisms. Because of high iron affinity, Fe(III)-siderophore complexes are stable, therefore, iron release from these complexes requires specialized strategies. These include Fe(III) reduction to Fe(II), change in coordination mode, proton assisted dissociation and siderophore degradation via esterases. (81,89−91) Esterase-mediated iron release has been described for the tris-catechol siderophore enterobactin and its glycosylated analogs, salmochelins, as early as 1971. (92−95) A similar degradation is observed in bacillibactin in Bacillus subtilis (96,97) and in Aspergillus fungi for fusarinines. (98−100) Although fusarinines and amphibactins are both hydroxamate siderophores, fusarinines contain an ester bond whereas amphibactins contain amide bonds. Therefore, the enzymatic degradation of fusarinines is carried out by esterases, unlike the proteolytic degradation proposed herein. Bacterial amidases have been shown to degrade the hydroxamate siderophore family of desferrioxamines, however, this degradation did not occur on the holo-siderophore (ferrioxamines), and the degraded product was used as a carbon and nitrogen source rather than for iron acquisition. (101−106) Furthermore, the degradation in these cases does not involve the peptide backbone amide bond. Nonenzymatic desferrioxamine degradation has been reported by the fungus Pyrenophora biseptata, involving the reduction of the hydroxamate moieties. (107) This degradation was proposed to lower the iron affinity of the desferrioxamine, as the chelating moieties are lost, and therefore increase iron availability to other microbes and plants. However, no degradation was observed for the ferri-siderophore suggesting that iron chelation protected the molecule from degradation. Another hydroxamate siderophore, ferrichrome, is degraded by Pseudomonas, again as a carbon and nitrogen source. (108−110) Siderophore modification as an iron release strategy has only been observed in catecholate-type siderophores. Catecholate-type siderophores possess the highest binding affinities and the bound Fe(III) exhibits an extremely low redox potential, necessitating this alternative method for iron release from the ferri-siderophore. (91) In contrast, hydroxamate siderophores typically utilize a reductive mechanism. (111) This redox mechanism for iron release has been proposed for amphibactins, as it is energetically favorable. (112) Nonetheless, the hydrolysis of a hexadentate hydroxamate siderophore to a tetradentate one shifts the Fe(III) redox potential, favoring its reduction into the bioavailable Fe(II) form and its dissociation from the complex. (113)
Siderophore tailoring has been observed for other amphiphilic hydroxamate siderophores, where cleavage of the acyl tail by an amide hydrolase produces the siderophore headgroup. (114) This degradation was carried out by a Marinobacter sp. bacterium on a variety of marine siderophores including the native marinobactins, and the xenosiderophores aquachelins, and loihichelins. (114) This hydrolysis is evidently different from the reaction described in this work, as the chelating groups remain unchanged. As such, the purpose for this enzymatic reaction is proposed to be related to siderophore availability and diffusion, since the acyl tail of this class of amphiphilic siderophores has been linked to membrane partitioning as a way to counter diffusion in the marine environment. (88,111) Nonetheless, this study constitutes another instance of siderophore biotransformation in bacterial cocultures revealing a possible common strategy in iron acquisition. Thus, to the best of our knowledge, this work is the first report of a hydroxamate degradation that involves hydrolysis of the peptide backbone.
One drawback of the siderophore-degradation strategy for iron release is the energetic strain for the bacteria, since it prevents the recycling of the siderophore. However, this disadvantage is circumvented if the siderophore-degrading bacteria is not the producer of the compound. This strategy has been observed in the enterobactin degradation by Pseudomonas aeruginosa, Campylobacter jejuni and Campylobacter coli, (115,116) all of which do not produce this compound but rather use it as a xenosiderophore. Thus, degradation of amphibactins by Microbulbifer sp. CNSA002 might serve two purposes. First, it lowers the affinity for iron so a stronger siderophore can steal it. The Microbulbifer sp. CNSA002 does have the genomic potential to produce two siderophores, a pyochelin-type siderophore and a predicted nonribosomal peptide synthetase-independent siderophore (Table S5 and Figure S15). Furthermore, genomic analysis revealed that CNSA002 has a TonB-dependent transporter (117) for siderophores, bacterial iron storage protein bacterioferritin, (118) and ferrichrome iron receptor involved in the uptake of iron in complex with ferrichrome. Second, Microbulbifer sp. may be able to import the degraded siderophore, which remains to be explored in future work.

Specificity of Siderophore Degradation

The hydroxamate moiety is found in several classes of marine derived siderophores including ferrioxamine, ferrichrome, marinobactins, moanachelins, acquachelins, acremonpeptides, and tenacibactins, to name a few. (77) To determine the specificity of siderophore degradation exhibited by Microbulbifer sp. CNSA002 we cocultured it with the desferrioxamine-producing Pseudoalteromonas sp. Cnat2–18.1 from our bacterial culture library. No degradation of apo- or Fe(III)-bound form of desferrioxamine was observed in coculture, as the levels detected in mono- and coculture were not significantly different (Figures 5A and S18). Similar observations were made when the media was supplemented with analytical commercially available standard of desferrioxamine B. Next, the possibility of ferrichrome degradation was also explored, by supplementation of Microbulbifer sp. CNSA002 culture with the siderophore in both Fe(III)- bound and unbound form. The controls where media is incubated with ferrichrome (Figure 5B, Ferrichrome) or desferrichrome (Figure 5B, Desferrichrome) showed that the compound was stable in the media conditions. No evident degradation was observed for either siderophore form in the presence of Microbulbifer sp. CNSA002. However, no ferrichrome was detected when the Microbulbifer sp. CNSA002 was incubated with ferrichrome (Figure 5B, Microbulbifer sp. CNSA002 + Ferrichrome). Instead, only non-Fe(III) bound form, desferrichrome, was detected. This is in contrast to the siderophore detection for ferrioxamines, where the detection of Fe(III)-bound form is not significantly different between the Pseudoalteromonas sp. monoculture and its coculture with Microbulbifer sp. CNSA002. This observation suggests that Microbulbifer sp. strain CNSA002 can acquire iron from ferrichrome but not from ferrioxamine. Indeed, a ferrichrome iron receptor to import ferrichrome inside the cell was found in the genome of Microbulbifer sp. CNSA002.
The inability of Microbulbifer sp. CNSA002 to degrade desferrioxamines and ferrichromes is not surprising, as these siderophores are purposefully selected to be nonpeptidic and cyclic, respectively. (101) We were unable to test the degradation of aquachelins, moanachelins, and marinobactins (Figure 5C), which are peptidic siderophores structurally similar to amphibactins due to nonavailability of producing bacteria. However, the possibility of Microbulbifer sp. CNSA002 to use both amphibactins and ferrichrome as xenosiderophores evidence the complex interactions in bacterial communities surrounding iron bioavailability. Since siderophores are secreted, they are considered public goods that can therefore be shared by cooperators or exploited by cheaters under siderophore piracy. (119,120) For instance, a strain of V. cyclitrophicus is able to shift its phenotype from siderophore producer to cheater in the presence of the exogenous siderophore desferrioxamine B. (121) Under these conditions, it is energetically favorable for this bacterium to produce the corresponding exogeneous siderophore receptor rather than to increase their own siderophore production to compete for iron. Siderophore cheaters are common in Vibrio, where it has been noted that genes encoding for siderophore receptors surpass the number of biosynthetic gene clusters for these molecules, and in some cases these BGCs are not even present, making the bacteria an obligate cheater. (122) Siderophores can also be used as a competitive strategy, locking iron and inducing iron starvation in competing bacteria. An example of this tactic has been found in Vibrio fischeri, a marine bacteria that secretes the siderophore aerobactin, limiting the growth of other Vibrio species. (123) The ability to obtain iron from different siderophores would give Microbulbifer sp. CNSA002 an advantage, utilizing public goods and circumventing iron starvation. The genus Microbulbifer has been previously described as biopolymer-degrading marine bacteria, which produces hydrolytic enzymes for the breakdown of cellulose, xylan, chitin, and gelatin. (124) We add to the biocatalytic capability of this genus by showing that some of the strains of these species can hydrolyze the backbone amide bond of peptidic hydroxamate siderophores.

Annotation and Variable Detection of Additional Natural Products

Using experimental and in silico spectral matching, several additional natural products were annotated in this data set. The production of some of these were found to be variable in mono- and coculture. Notably, several of these natural products, including clusters of bulbiferamides, prodigiosins, and bromotryptamines are either not detected in coculture with V. coralliilyticus Cn52-H1 or detected at significantly higher intensity in monoculture (visualized as pie chart representation in FBMN (Figures 2A and S1)) and as boxplots (Figure 6). The antimicrobial natural product prodigiosin (53) was detected in the monocultures of the Pseudoalteromonas sp. strains AC-K1-M-019 and DL2H-2.2. However, no production was observed in coculture. A similar trend was observed for prodigiosin analogs annotated, including cycloprodigiosin and heptyl prodigiosin. This family of compounds exhibit a wide range of bioactivity including anticancer, antimicrobial, antialgal, and antiparasitic properties. (125−132) Similarly, bulbiferamides were detected only in monoculture of Microbulbifer sp. CNSA002. These compounds are recently described ureidohexapeptides with antitrypanosomal activity. (60,62) Additionally, several brominated tryptamines were detected in monoculture of Pseudoalteromonas sp. DL2H-2.2 and not in coculture. Brominated indoles have been previously isolated from marine sponges and bryozoans, exhibiting antioxidant activity and anti-inflammatory. (133−136) Although there is no mention of a bacterial origin for these brominated compounds in sponges and bryozoans, it is common for marine natural products to be attributed to the animal host, even though they are often of bacterial origin. (137) This observation is further supported by the identification of bioactive bromotryptamine analogs produced by the marine bacterium Pseudoalteromonas rubra. (138) However, the possibility that these compounds are produced both by the host and animal cannot be eliminated. In a similar vein, we annotated multiple azulene analogs produced by Pseudoalteromonas sp. AC-K1-M-019 as well as Pseudoalteromonas sp. DL2H-2.2. These compounds are guaiane sesquiterpenes, which have been reported in different marine organisms such as corals and sponges. (139−141) Compounds from this family have exhibited bioactivity against Leishmania and tumor cell lines, as immunomodulators, anti-inflammatory, antibacterial, antiviral and antiproliferative. (142−149)

Figure 6

Figure 6. Boxplots of the relative abundances of bulbiferamide A, prodigiosin and bromotryptamine as well as a representative panel of N-acyl amides, in monoculture and coculture conditions. Asterisks indicate significant differences between the compared groups.

Another class of compounds that was differentially detected between mono- and cocultures are N-acyl amides. We annotated a large diversity of this class of compounds (Figure S21 and Table S6) and observed differential detection of this class of compounds in monocultures of different strains as well as the in coculture of Cn52-H1 and CNSA002. Several of these compounds, produced by V. coralliilyticus Cn52-H1, were not detected in its coculture with Microbulbifer sp. CNSA002, as evidenced by the top50 feature heatmap (Figure S2 and Table S1). This class of features was detected across the board, with a large structural diversity for both the headgroup and acyl chain (Table S6). The highest number of annotated N-acyl amides was detected in Pseudoalteromonas sp. Cnat2–18.1 monocultures, including 15 N-acyl amides unique to this condition (Figure S22). Photobacterium sp. Ofav2–7 also stands out due to the number of unique members including citrulline headgroup containing N-acyl amides. N-acyl amides are ubiquitous in nature, as they are endogenous signaling molecules consisting of an amino acid covalently bound to a fatty acid. (150) Despite their prevalence, their functions and biological mechanisms are largely understudied. Most of our knowledge about N-acyl amides (also known as lipoamino acids and elmiric acids) are described in human samples, where they are involved in inflammation, homeostasis and illnesses such as diabetes, cancer and neurodegenerative and cardiovascular diseases. (151−154) In bacteria, N-acyl amides were shown to play a role in virulence, (155) signaling, (156,157) as antibiotics, (158−160) surfactants, (161) as a part of the membrane lipids (162,163) and protein sorting systems. (164) In our case, whether these molecules play a role as a chemical cue or antimicrobials remains to be explored.
The differential production of secondary metabolites by Pseudoalteromonas sp. and Microbulbifer sp. in coculture with V. coralliilyticus Cn52-H1 denotes natural product suppression upon coculture with V. coralliilyticus Cn52-H1. As observed in Figure 2B, 10% of features were uniquely detected in monoculture. Previously, subinhibitory concentrations of andrimid had been shown to elicit expression of silent biosynthetic gene clusters, particularly the induction of holomycin, in Photobacterium galatheae through a general stress response mechanism. (67) However, when challenged with subinhibitory concentrations of another antibiotic, trimethoprim, natural product detection was attenuated corresponding to an SOS response. (67) Therefore, the natural product suppression herein described could be attributed to multiple factors. As was observed for holomycin, different antibiotic elicitors can have varied effects on secondary metabolite production. Thus, exposure of these bacteria to andrimid or a different small molecule produced by V. coralliilyticus Cn52-H1 could result in inhibition of natural product biosynthesis, explaining why several natural products are only detected in monoculture and not in coculture. Depending upon the partner, cocultures can exhibit symbiotic interactions among its members such as parasitism, commensalism or mutualism. (165) They can also display antagonistic relationships, through competition or predation. (165) Due to antibiotic hormesis, increased exposure could lead to the observed inhibition. (166) Natural product-mediated alteration of microbial species composition and interactions have been described in other environments also. (167) Thus, cocultivation between different bacteria can aid in deciphering the interspecies interactions at play in the natural environment and allow for selection of phenotypes that may be beneficial to that environment.

Conclusions

Click to copy section linkSection link copied!

The coinfections by opportunistic pathogens during heat and other stressors is a major obstacle to the recovery of coral reefs akin to challenging recovery when infections of humans by SARS-COV-2 result in bacterial pneumonia. Furthermore, the opportunistic coral pathogens are often normal microflora of coral reefs, but their abundance increases during stressors resulting in exacerbation of disease. Thus, beneficial bacteria that can keep the pathogens at bay are a useful strategy to prevent coinfections. However, elucidating chemical interactions between these microbes in the native environment is challenging. In this work, we elucidated chemical interactions between coral-derived beneficial and pathogenic bacteria using discovery-centered untargeted metabolomics approach. Using this approach, we discovered a previously unknown tailoring of pathogen-synthesized peptide siderophores by the beneficial bacteria limiting their affinity for iron. Since iron is limited in the marine environment and the requirement for iron-dependent metabolic activity is large, siderophore production occurs widely in the marine environment. Thus, withholding iron from a pathogen is an important strategy to limit their proliferation. Furthermore, there is a fine balance between benefits and harmful effects of excess iron in coral reefs. On one side, iron is essential for the functioning of the microbiome, the endosymbiotic algae that reside inside coral cells, while excess iron can result in harmful phytoplankton blooms. Thus, maintaining healthy iron-levels through community interactions is important to the health of reefs. In the future, implications of this biotransformation in both the producer (V. coralliilyticus) and the coculture partner are important to study as a complex dynamic surrounding iron acquisition may be involved. For example, can this beneficial bacteria rescue overgrowth of Vibrio spp. bacteria in coral colonies under high heat conditions? Amphibactin is among the most-abundant siderophores detected in both the Atlantic and Pacific Ocean. Thus, our discovery of amphibactin degradation has important ecological implications. Further, biochemical experiments involving activity-based protein profiling will aid in identification of the specific protease in the protein fraction that is responsible for this activity. Lastly, our chemistry-first metabolomics approach has led us to the identification of this microbial interaction which would otherwise be missed by a genomics-first approach and can be potentially exploited to engineer microbiomes with higher resilience to iron starvation strategies from opportunistic pathogens.

Methods

Click to copy section linkSection link copied!

Bacterial Isolation

A. cervicornis corals were sampled at the Georgia Aquarium and the fragments were stored in FASW at room temperature during. Mucus samples (2 mL) were collected from each fragment. Subsequently, the coral tissue was separated from the skeleton using an Iwata Siphon Feed Airbrush and collected in a sterile bag. The remaining skeleton was placed in a culture tube containing 5 mL of salt water broth (SWB (39)) and incubated at 30 °C for 48 h. The mucus, tissue slurry, and skeleton culture were diluted 5× and 10× before plating. A total of 36 samples were plated onto six different media: salt water agar (SWA), half-strength marine broth (Marine Broth 2216, BD Difco), Luria broth agar (LB, BD Difco), International Streptomyces Project-2 medium agar (ISP2, BD Difco), tryptic soy agar (TSA, BD Difco) and thiosulfate-citrate-bile salts-sucrose agar (TCBS, BD Difco). Plates were incubated at 30 °C for up to 10 days. Individual, morphologically distinct, colonies were subsequently streaked multiple times in the appropriate media for purification. Stock cultures of the 119 purified strains were prepared in 25% glycerol and frozen at −80 °C. Additional isolates were received from Dr. Valerie Paul at the Smithsonian Marine Station, isolated from corals Montastraea cavernosa, C. natans, Pseudodiploria strigosa, O. faveolata and D. labyrinthiformis. (23) Several isolates were received from Dr. Vinayak Agarwal, Georgia Institute of Technology and were isolated from marine sponges S. aurea, Aplysina fulva, and Aiolochroia crassa. (66)

Bacterial Coculturing

Morphologically diverse bacteria (Table 1) were prioritized for coculturing with V. coralliilyticus Cn52-H1 in triplicate, based on pigment production, taxonomic identification or their previous identification as potentially beneficial probiotic strains. (23) Individual bacteria were also cultured in axenic culture in triplicates. Each strain was inoculated in 250 mL flasks containing 22 mL of SWB to an OD600 of 0.05. For cocultures, each isolate and V. coralliilyticus Cn52-H1 were inoculated together at an OD600 of 0.05 each. The cultures were incubated at 30 °C, shaking at 200 rpm for 24 h. Cultures were harvested and aliquoted into two 10 mL portions. The first portion was extracted using a liquid–liquid extraction (LLE) with ethyl acetate (EtOAc). Briefly, 10 mL of EtOAc was added to this portion, and then vortexed vigorously, and centrifuged at 2000g for 3 min. The extraction was repeated once more and the organic layers were removed with a glass pipet, pooled and dried in vacuo using a SpeedVac (Thermo Scientific, Waltham, MA). The second portion was centrifuged twice at 5250g for 15 min to separate the cell pellet from the supernatant. The supernatant was extracted via solid-phase extraction (SPE) using a 100 mg C18 column (Thermo Scientific, Waltham, MA), whereas the cell pellet was extracted using a solid–liquid extraction (SLE) with a 2:2:1 ethyl acetate:methanol:water (EtOAc:MeOH:H2O) solvent system. The SPE was performed by washing the column with 5 mL of 100% acetonitrile (MeCN), equilibrating with 5 mL of H2O and loading the supernatant to the column. Analytes bound to the column were eluted with 2.5 mL of 20%, 50% and 100% MeCN, eluates were pooled into a single extract and dried in vacuo. For the SLE, 6.7 mL of 2:2:1 EtOAc:MeOH:H2O were added to the cell pellet and vortexed vigorously every 30 min for 5 h. The extract was then centrifuged at 5250g for 15 min to remove the debris and dried in vacuo. Extracts were stored at −20 °C until data acquisition.
Microbulbifer sp. CNSA002 was also incubated with a cell-free supernatant of V. coralliilyticus Cn52-H1 and vice versa. Cell-free supernatants were prepared by freezing a 50 mL bacterial culture, thawing of the frozen culture, and centrifuging at 5250g for 15 min (performed twice). Supernatants were then filtered through a PES 0.2 μm membrane twice. For supernatant experiments, SWB was supplemented in a 1:1 ratio with each supernatant (22 mL total) and inoculated with the corresponding bacteria to an OD600 of 0.05. Monoculture controls were inoculated in 1:1 sterile SWB:FASW. Cultures were incubated at 30 °C, shaking at 200 rpm for 24 h and extracted using SPE as previously described. Supernatant controls were incubated and extracted in the same manner.
Other Microbulbifer sp. strains from our bacterial library were cocultured with V. coralliilyticus Cn52-H1, including VASA003, ZMAC003, VAAF005, MKSA007, and MLAF003. Incubation and metabolite extraction were performed as previously described.

Untargeted Metabolomics Data Acquisition and Analysis

The dried extracts were resuspended in 300 μL of 100% MeOH containing 1 μM of sulfadimethoxine as an internal standard. Samples were vortexed, sonicated for 10 min and centrifuged at 16,160g for 15 min. The resuspended extracts were analyzed using an Agilent 1290 Infinity II Ultra High-Pressure Liquid Chromatography (UHPLC) system (Agilent Technologies; Santa Clara, CA) with a Kinetex 1.7 μm C18 reversed phase UHPLC column (50 × 2.1 mm2) (Phenomenex; Torrance, CA) coupled to an ImpactII ultrahigh resolution Qq-ToF mass spectrometer (Bruker Daltonics, GmbH, Bremen, Germany) equipped with an electrospray ionization (ESI) source. Chromatographic separation was performed with the following mobile phase gradient: 5% solvent B (MeCN, 0.1% (v/v) formic acid) and 95% solvent A (H2O, 0.1% (v/v) formic acid) for 3 min, a linear gradient of 5% B–95% B over 17 min, held at 95% B for 3 min, 95% B–5% B in 1 min, and held at 5% B for 1 min, 5% B- 95% B in 1 min, held at 95% B for 2 min, 95% B–5% B in 1 min, and held at 5% B for 2.5 min, at a flow rate of 0.5 mL/min throughout. MS spectra were acquired in positive ionization mode from m/z 50 to 2000 Da. An external calibration with ESI-L Low Concentration Tuning Mix (Agilent Technologies) was performed prior to data collection, and hexakis(1H,1H,2H-perfluoroethoxy)phosphazene was used as an internal lock-mass calibrant throughout the run. For MS2 data acquisition, the eight most intense ions per MS1 were selected for fragmentation. A basic stepping function was used to fragment ions at 50 and 125% of the CID calculated for each m/z with timing of 50% for each step. The MS/MS active exclusion parameter was set to two, and the active exclusion was released after 30s. The mass of the internal lock-mass calibrant was excluded from the MS2 list. UV data was acquired with a UV DAD detector (Agilent Technologies) from 190 to 400 nm, with a 2 nm step. Zero offset was set at 5% along a 1000 mAU attenuation. Data was acquired throughout the LC run with a >0.1 min peak width.
Raw data were converted to mzXML format, using vendor proprietary software. Metabolite features were extracted using MZmine 2.53, (68) performing mass detection, chromatogram building, chromatogram deconvolution, isotopic peak grouping, retention time alignment, replicate filtering, duplicate peak removal, and gap filling. The resulting processed data was submitted to the Global Natural Product Social Molecular Network platform (GNPS) to generate a feature-based molecular network (FBMN). The molecular network was generated using the following parameters: fragment ions were removed within a ±17 Da window of the precursor m/z, precursor ion and fragment ion mass tolerance were set to 0.02 Da and edges were filtered to have a score above 0.7 and at least 4 matched peaks. Edges were kept if both nodes were present in each other’s top 10 most similar nodes, and molecular families’ maximum size was set to 100. Experimental fragmentation spectra were searched against GNPS’s spectral libraries and filtered in the same way (cosine score above 0.7 and a minimum of 4 matched peaks). The workflows for DEREPLICATOR, (168) DEREPLICATOR+, (169) MolDiscovery (170) and MS2LDA (74) were also run on GNPS. The output from MZmine was additionally exported for analysis with SIRIUS (72) 5.3.6. with CSI:FingerID (171) and CANOPUS. (73) These tools provide putative annotations, which are confirmed using an MS2 spectral comparison with literature reported spectra, in-house spectra, with data acquired on analytical standards, and manual annotation of MS2 fragments resulting in level 2 compound annotations. SIRIUS computes putative chemical formulas using MS1 and fragmentation trees (based on user uploaded MS1 isotopic peaks and MS2 fragmentation patterns). CSI: FingerID transforms MS2 spectra into predicted structural fingerprints that enable matching to chemical databases. CANOPUS predicts the chemical class of metabolites by utilizing CSI:FingerID’s predicted structural fingerprints. Library searches were performed for The Natural Product Atlas (75) and MarinLit. (76) The molecular network was visualized using Cytoscape (70) v3.9.0 and features present in the blanks were subtracted. UpSet plots were generated using the Intervene (71) platform, to facilitate data visualization and statistical analysis were performed on the Metaboanalyst platform. (172)

Fermentation, Extraction, and Compound Purification

Microbulbifer sp. CNSA002 and V. coralliilyticus Cn52-H1 were inoculated at an OD600 of 0.05 in 1 L flasks containing 200 mL of SWB. Cultures were incubated at 30 °C, shaking at 200 rpm for 24 h. Harvested cultures (5 L) were centrifuged at 4920g for 25 min at 4 °C to separate the cell pellet from supernatant. The cell-free supernatant was mixed with 4% (w/v) XAD-16 resin (Sigma-Aldrich, St. Louis, MO) and stirred for 16 h. Afterward, the supernatant was removed, and the resin was washed with 500 mL of H2O and eluted with 200 mL of ethanol (EtOH). The solvent was dried in vacuo to yield a 1.7 g crude extract.
The crude extract was resuspended in H2O and fractionated via reverse phase liquid chromatography (RPLC) using a 10 g C18 column (Thermo Scientific, Waltham, MA). The column was washed with 150 mL of MeCN and equilibrated with 150 mL of H2O. The crude was loaded, and the analytes were eluted with 10, 20, 40 60 and 100% MeCN to obtain five fractions (1–5) which were dried in vacuo. Fraction 3 (40% MeCN) was further fractionated using an Agilent 1260 Infinity II Liquid Chromatography (semipreparative HPLC) system (Agilent Technologies) equipped with a Luna 5 μm C18 reversed phase HPLC column (250 × 10 mm2) (Phenomenex). The mobile phases used for chromatographic separation were solvent B: MeCN, 0.1% (v/v) trifluoroacetic acid (TFA) and solvent A: H2O, 0.1% (v/v) TFA. The gradient was performed with the following mobile phase compositions: a linear gradient from 10% solvent B to 100% solvent B in 25 min, held at 100% B for 10 min, at a flow rate of 2 mL/min throughout. Elution was monitored with a UV detector monitoring the run at 205 and 310 nm. This fractionation yielded compound 1 (3.0 mg).
Compound 1: yellow, oily. 1H and 13C NMR data, see Table S4. Positive HRESIMS m/z 617.4121 [M + H]+ (calculated for C30H57N4O9, 617.4120)
One-dimensional (1D) and two-dimensional (2D) NMR spectra were recorded on a Bruker Avance III HD 700 MHz NMR, in DMSO-d6 and calibrated using residual undeuterated solvent as internal reference. The chemical shift (δ) is reported in parts per million (ppm) and the coupling constants (J values) are in Hz. NMR data for compound 1 has been deposited to NP-MRD (173) (ID: NP0341873).

O-CAS Agar Assay

The iron chelating activity of Compound 1 was confirmed via a modified CAS assay (O-CAS (80)). A 1 μL aliquot of a 1 mg/mL methanolic solution of compound 1 was spotted on an O-CAS agar plate. (80) Desferrioxamine mesylate (Sigma-Aldrich) 1 mg/mL was used as a positive control, whereas methanol was spotted as a negative control. The plate was incubated at room temperature for 30 min before registering the results. An O-CAS agar plate was also overlaid on a colony of Microbulbifer sp. CNSA002 grown on SWA.

CNSA002 Whole Genome Sequencing

The cell pellet from 2 mL of Microbulbifer sp. CNSA002 culture was collected by centrifugation at 16000g for 2 min. The cell pellet was solubilized in a 120 μL aliquot of 10 mg/mL lysozyme in 10 mM Tris–HCl, pH 8.0 buffer and incubated at 37 °C for 45 min. Cells were collected by centrifugation and gDNA was isolated following the Wizard Genomic DNA purification kit (Promega) specifications. The size of gDNA was checked on a 0.5% agarose gel at 120 V for 40 min. The quality and concentration of gDNA was measured on a NanoDrop spectrophotometer (Thermo Scientific). Samples were sent for sequencing to SeqCenter (Pittsburgh), and Illumina and Nanopore sequencing were performed. The genome sequence has been deposited to NCBI under the bioproject PRJNA1173768.

Enzymatic Hydrolysis of Amphibactin

To test the enzymatic nature of the amphibactin degradation, a 20 mL aliquot of SWB was inoculated with Microbulbifer sp. CNSA002 and incubated at 30 °C for 24 h, shaking at 200 rpm. The cell pellet and culture supernatant were separated by centrifugation at 4920g for 45 min at 4 °C. A 10 mL aliquot of phosphate buffer (50 mM Na3PO4, pH 7.0) was added to the cell pellet and subsequently sonicated on ice for 30 min (40% amplitude, 20 s on, 40 s off) to obtain the cell lysate. The culture supernatant and cell lysate were tested for protease activity. A portion of each fraction was boiled at 95 °C for 10 min to denature the proteins and tested for protease activity. The culture supernatant was additionally fractionated using two molecular weight cutoff (MWCO) Amicon ultracentrifugation filters (3 kDa and 10 kDa, Sigma-Aldrich) and the four resulting fractions were tested for activity.
In order to assay the activity of each fraction, the amphibactin-containing V. coralliilyticus Cn52-H1 cell-free supernatant was employed. A 900 μL aliquot of V. coralliilyticus Cn52-H1 cell-free supernatant was supplemented with 100 μL of each fraction. Reactions were incubated at 30 °C, shaking at 200 rpm overnight and extracted via SPE. The SPE was performed using a 25 mg C18 column (Thermo Scientific, Waltham, MA). The columns were washed with 1 mL of 100% MeCN and equilibrated with 1 mL of H2O. The reactions were loaded into the column and analytes bound to the column were eluted with 1 mL of 20, 50 and 100% MeCN. Eluates were pooled into a single extract, dried in vacuo and stored at −20 °C until data acquisition. The dried extracts were resuspended in 60 μL of 100% MeOH containing 1 μM of sulfadimethoxine as an internal standard. Samples were prepared and LCMS data was acquired as previously detailed.

Ferrichrome and Desferrioxamine Degradation Assays

To determine if Microbulbifer sp. CNSA002 can degrade the siderophore ferrichrome (Sigma-Aldrich), a 15 mL aliquot of SWB was supplemented with either desferrichrome or ferrichrome (6.67 μM) and inoculated with Microbulbifer sp. CNSA002. Controls for both the apo- and holosiderophore, as well as for the bacterium and media control were set up. To test for desferrioxamine degradation, cocultures of Microbulbifer sp. CNSA002 and the desferrioxamine-producing Pseudoalteromonas sp. Cnat2–18.1 were inoculated. A Microbulbifer sp. CNSA002 was cultured in SWB supplemented with desferrioxamine B (0.6 mM) (Sigma-Aldrich). Monocultures of each bacteria and for the media were set up. Cultures were incubated at 30 °C for 24 h, shaking at 200 rpm. Cultures were harvested and extracted via SPE, dried down and reconstituted for LC-MS/MS analysis as previously described.

Data Availability

Click to copy section linkSection link copied!

Mirobulbifer sp. CNSA002 whole genome sequence has been deposited in NCBI under the bioproject PRJNA1173768. NMR data for compound 1 has been deposited to NP-MRD (173) (ID: NP0341873). LCMS data has been deposited in GNPS-MassIVE and the data set ID is MSV000096127.

Supporting Information

Click to copy section linkSection link copied!

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acs.biochem.4c00706.

  • Representative feature-based molecular networking for mono- and coculture experiments (Figure S1); Heatmap of the top 50 features in monocultures and coculture of V. coralliilyticus Cn52-H1 and Microbulbifer sp. CNSA002 (Figure S2); natural product extraction and characterization workflow (Figure S3); amphibactin F degradation product, elucidated through 1D and 2D NMR experiments (Figure S4); NMR data for compound 1 (Figures S5–S12); MS2 spectral analysis of amphibactins and new amphibactin analogs (Figures S13 and S14); Microbulbifer sp. CNSA002 O-CAS agar assay (Figure S15); detection of degraded amphibactins in V. coralliilyticus Cn52-H1 in coculture with Microbulbifer sp. CNSA002 and supplemented with Microbulbifer sp. CNSA002 supernatant and CNSA002 fractions (Figures S16 and17); Boxplot of the relative abundances of desferrioxamine G and ferrioxamine G in Pseudoalteromonas sp. Cnat2–18.1 and Microbulbifer sp. CNSA002 monocultures and coculture (Figure S18); mirror plots comparing experimental MS2 spectra of natural products, hydroxamate siderophores and N-acyl amides detected in this study with spectra deposited in the GNPS library (Figures S19–21); upset plot for N-acyl amides detected in different monocultures and cocultures (Figure S22); putative annotation of top 50 features present in the V. coralliilyticus Cn52-H1 and Microbulbifer sp. CNSA002 coculture heatmap (Table S1); putative annotation of 76 features uniquely detected in marine bacteria cocultures with V. coralliilyticus Cn52-H1 (Table S2); list of annotated metabolites detected in this study (Table S3); 1H (700 MHz) and 13C (176 MHz) NMR data of compound 1 in DMSO-d6 (Table S4); biosynthetic gene clusters present in Microbulbifer sp. bacteria analyzed in this study (Table S5); list of annotated N-acyl amides detected in this study (Table S6) (PDF)

Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Author Information

Click to copy section linkSection link copied!

  • Corresponding Author
    • Neha Garg - School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United StatesCenter for Microbial Dynamics and Infection, Georgia Institute of Technology, 315 Ferst Drive, Atlanta, Georgia 30332, United StatesOrcidhttps://orcid.org/0000-0002-2760-7123 Email: [email protected]
  • Authors
    • Mónica Monge-Loría - School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
    • Weimao Zhong - School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
    • Nadine H. Abrahamse - School of Chemistry and Biochemistry, Georgia Institute of Technology, 950 Atlantic Drive, Atlanta, Georgia 30332, United States
    • Stephen Hartter - Georgia Aquarium, 225 Baker St. NW, Atlanta, Georgia 30313, United States
  • Notes
    The authors declare no competing financial interest.

Acknowledgments

Click to copy section linkSection link copied!

This work was supported by the NIH R35GM150870 to N.G. We thank Dr. Valerie Paul at the Smithsonian Marine Station, Dr. Vinayak Agarwal, Georgia Institute of Technology and Dr. Blake Ushijima, UNCW for sharing their bacterial strains with us. We thank Dr. Vinayak Agarwal for his support in NMR data acquisition and compound isolation. We thank Dr. Alistair Dove and the entire research team of Georgia Aquarium for giving us the opportunity to work with them.

References

Click to copy section linkSection link copied!

This article references 173 other publications.

  1. 1
    Knowlton, N.; Brainard, R. E.; Fisher, R.; Moews, M.; Plaisance, L.; Caley, M. J. Coral Reef Biodiversity; Wiley-Blackwell, 2010.
  2. 2
    Sang, V. T.; Dat, T. T. H.; Vinh, L. B.; Cuong, L. C. V.; Oanh, P. T. T.; Ha, H.; Kim, Y. H.; Anh, H. L. T.; Yang, S. Y. Coral and Coral-Associated Microorganisms: A Prolific Source of Potential Bioactive Natural Products. Mar. Drugs 2019, 17 (8), 468  DOI: 10.3390/md17080468
  3. 3
    McCauley, E. P.; Piña, I. C.; Thompson, A. D.; Bashir, K.; Weinberg, M.; Kurz, S. L.; Crews, P. Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates. J. Antibiot. 2020, 73 (8), 504525,  DOI: 10.1038/s41429-020-0330-5
  4. 4
    Srinivasan, R.; Kannappan, A.; Shi, C.; Lin, X. Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds. Mar. Drugs 2021, 19 (10), 530  DOI: 10.3390/md19100530
  5. 5
    Dinarvand, M.; Spain, M. Identification of Bioactive Compounds from Marine Natural Products and Exploration of Structure-Activity Relationships (SAR). Antibiotics 2021, 10 (3), 337  DOI: 10.3390/antibiotics10030337
  6. 6
    Cappello, E.; Nieri, P. From Life in the Sea to the Clinic: The Marine Drugs Approved and under Clinical Trial. Life 2021, 11 (12), 1390  DOI: 10.3390/life11121390
  7. 7
    Haefner, B. Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today 2003, 8 (12), 536544,  DOI: 10.1016/S1359-6446(03)02713-2
  8. 8
    Knowlton, N.; Rohwer, F. Multispecies Microbial Mutualisms on Coral Reefs: The Host as a Habitat. Am. Nat. 2003, 162 (S4), S51S62,  DOI: 10.1086/378684
  9. 9
    Simon, J.-C.; Marchesi, J. R.; Mougel, C.; Selosse, M.-A. Host-microbiota interactions: from holobiont theory to analysis. Microbiome 2019, 7 (1), 5  DOI: 10.1186/s40168-019-0619-4
  10. 10
    Bewley, C. A.; Holland, N. D.; Faulkner, D. J. Two classes of metabolites from Theonella swinhoei are localized in distinct populations of bacterial symbionts. Experientia 1996, 52 (7), 716722,  DOI: 10.1007/BF01925581
  11. 11
    Piel, J. Metabolites from symbiotic bacteria. Nat. Prod. Rep. 2004, 21 (4), 519538,  DOI: 10.1039/b310175b
  12. 12
    König, G. M.; Kehraus, S.; Seibert, S. F.; Abdel-Lateff, A.; Müller, D. Natural products from marine organisms and their associated microbes. Chembiochem 2006, 7 (2), 229238,  DOI: 10.1002/cbic.200500087
  13. 13
    Vanwonterghem, I.; Webster, N. S. Coral Reef Microorganisms in a Changing Climate. iScience 2020, 23 (4), 100972  DOI: 10.1016/j.isci.2020.100972
  14. 14
    Indraningrat, A. A. G.; Steinert, G.; Becking, L. E.; Mueller, B.; de Goeij, J. M.; Smidt, H.; Sipkema, D. Sponge holobionts shift their prokaryotic communities and antimicrobial activity from shallow to lower mesophotic depths. Antonie van Leeuwenhoek 2022, 115 (10), 12651283,  DOI: 10.1007/s10482-022-01770-4
  15. 15
    Swaminathan, S. D.; Meyer, J. L.; Johnson, M. D.; Paul, V. J.; Bartels, E.; Altieri, A. H. Divergent responses of the coral holobiont to deoxygenation and prior environmental stress. Front. Mar. Sci. 2024, 10, 1301474  DOI: 10.3389/fmars.2023.1301474
  16. 16
    Stévenne, C.; Micha, M.; Plumier, J.-C.; Roberty, S. Corals and Sponges Under the Light of the Holobiont Concept: How Microbiomes Underpin Our Understanding of Marine Ecosystems. Front. Mar. Sci. 2021, 8, 698853  DOI: 10.3389/fmars.2021.698853
  17. 17
    Webster, N. S.; Reusch, T. B. H. Microbial Contributions to the Persistence of Coral Reefs. ISME J. 2017, 11 (10), 21672174,  DOI: 10.1038/ismej.2017.66
  18. 18
    Reshef, L.; Koren, O.; Loya, Y.; Zilber-Rosenberg, I.; Rosenberg, E. The coral probiotic hypothesis. Environ. Microbiol. 2006, 8 (12), 20682073,  DOI: 10.1111/j.1462-2920.2006.01148.x
  19. 19
    Eddy, T. D.; Lam, V. W. Y.; Reygondeau, G.; Cisneros-Montemayor, A. M.; Greer, K.; Palomares, M. L. D.; Bruno, J. F.; Ota, Y.; Cheung, W. W. L. Global decline in capacity of coral reefs to provide ecosystem services. One Earth 2021, 4 (9), 12781285,  DOI: 10.1016/j.oneear.2021.08.016
  20. 20
    Humanes, A.; Lachs, L.; Beauchamp, E.; Bukurou, L.; Buzzoni, D.; Bythell, J.; Craggs, J. R. K.; de la Torre Cerro, R.; Edwards, A. J.; Golbuu, Y.; Martinez, H. M.; Palmowski, P.; van der Steeg, E.; Sweet, M.; Ward, A.; Wilson, A. J.; Guest, J. R. Selective breeding enhances coral heat tolerance to marine heatwaves. Nat. Commun. 2024, 15 (1), 8703  DOI: 10.1038/s41467-024-52895-1
  21. 21
    Ushijima, B.; Gunasekera, S. P.; Meyer, J. L.; Tittl, J.; Pitts, K. A.; Thompson, S.; Sneed, J. M.; Ding, Y.; Chen, M.; Jay Houk, L.; Aeby, G. S.; Häse, C. C.; Paul, V. J. Chemical and genomic characterization of a potential probiotic treatment for stony coral tissue loss disease. Commun. Biol. 2023, 6 (1), 248  DOI: 10.1038/s42003-023-04590-y
  22. 22
    Peixoto, R. S.; Rosado, P. M.; de Assis Leite, D. C.; Rosado, A. S.; Bourne, D. G. Beneficial Microorganisms for Corals (BMC): Proposed Mechanisms for Coral Health and Resilience. Front. Microbiol. 2017, 8, 341  DOI: 10.3389/fmicb.2017.00341
  23. 23
    Deutsch, J. M.; Mandelare-Ruiz, P.; Yang, Y.; Foster, G.; Routhu, A.; Houk, J.; De La Flor, Y. T.; Ushijima, B.; Meyer, J. L.; Paul, V. J.; Garg, N. Metabolomics Approaches to Dereplicate Natural Products from Coral-Derived Bioactive Bacteria. J. Nat. Prod. 2022, 85 (3), 462478,  DOI: 10.1021/acs.jnatprod.1c01110
  24. 24
    Sweet, M.; Villela, H.; Keller-Costa, T.; Costa, R.; Romano, S.; Bourne, D. G.; Cárdenas, A.; Huggett, M. J.; Kerwin, A. H.; Kuek, F.; Medina, M.; Meyer, J. L.; Müller, M.; Pollock, F. J.; Rappé, M. S.; Sere, M.; Sharp, K. H.; Voolstra, C. R.; Zaccardi, N.; Ziegler, M.; Peixoto, R.; Bouskill, N.; Speare, L.; Shore, A. Insights into the Cultured Bacterial Fraction of Corals. mSystems 2021, 6 (3), e0124920  DOI: 10.1128/mSystems.01249-20
  25. 25
    Ziegler, M.; Seneca, F. O.; Yum, L. K.; Palumbi, S. R.; Voolstra, C. R. Bacterial community dynamics are linked to patterns of coral heat tolerance. Nat. Commun. 2017, 8, 14213  DOI: 10.1038/ncomms14213
  26. 26
    Flórez, L. V.; Biedermann, P. H. W.; Engl, T.; Kaltenpoth, M. Defensive symbioses of animals with prokaryotic and eukaryotic microorganisms. Nat. Prod. Rep. 2015, 32 (7), 904936,  DOI: 10.1039/C5NP00010F
  27. 27
    Uria, A.; Piel, J. Cultivation-independent approaches to investigate the chemistry of marine symbiotic bacteria. Phytochem. Rev. 2009, 8 (2), 401414,  DOI: 10.1007/s11101-009-9127-7
  28. 28
    Ritchie, K. B. Regulation of Microbial Populations by Coral Surface Mucus and Mucus-Associated Bacteria. Mar. Ecol.: Prog. Ser. 2006, 322, 114,  DOI: 10.3354/meps322001
  29. 29
    Raina, J.-B.; Tapiolas, D.; Motti, C. A.; Foret, S.; Seemann, T.; Tebben, J.; Willis, B. L.; Bourne, D. G. Isolation of an antimicrobial compound produced by bacteria associated with reef-building corals. PeerJ 2016, 4, e2275  DOI: 10.7717/peerj.2275
  30. 30
    Kvennefors, E. C. E.; Sampayo, E.; Kerr, C.; Vieira, G.; Roff, G.; Barnes, A. C. Regulation of Bacterial Communities Through Antimicrobial Activity by the Coral Holobiont. Microb. Ecol. 2012, 63 (3), 605618,  DOI: 10.1007/s00248-011-9946-0
  31. 31
    Delgadillo-Ordoñez, N.; Garcias-Bonet, N.; Raimundo, I.; García, F. C.; Villela, H.; Osman, E. O.; Santoro, E. P.; Curdia, J.; Rosado, J. G. D.; Cardoso, P.; Alsaggaf, A.; Barno, A.; Antony, C. P.; Bocanegra, C.; Berumen, M. L.; Voolstra, C. R.; Benzoni, F.; Carvalho, S.; Peixoto, R. S. Probiotics reshape the coral microbiome in situ without detectable off-target effects in the surrounding environment. Commun. Biol. 2024, 7 (1), 434  DOI: 10.1038/s42003-024-06135-3
  32. 32
    Papke, E.; Carreiro, A.; Dennison, C.; Deutsch, J. M.; Isma, L. M.; Meiling, S. S.; Rossin, A. M.; Baker, A. C.; Brandt, M. E.; Garg, N.; Holstein, D. M.; Traylor-Knowles, N.; Voss, J. D.; Ushijima, B. Stony coral tissue loss disease: a review of emergence, impacts, etiology, diagnostics, and intervention. Front. Mar. Sci. 2024, 10, 1321271  DOI: 10.3389/fmars.2023.1321271
  33. 33
    Vidal-Dupiol, J.; Ladrière, O.; Meistertzheim, A. L.; Fouré, L.; Adjeroud, M.; Mitta, G. Physiological responses of the scleractinian coral Pocillopora damicornis to bacterial stress from Vibrio coralliilyticus. J. Exp. Biol. 2011, 214 (Pt 9), 15331545,  DOI: 10.1242/jeb.053165
  34. 34
    Roder, C.; Arif, C.; Bayer, T.; Aranda, M.; Daniels, C.; Shibl, A.; Chavanich, S.; Voolstra, C. R. Bacterial profiling of White Plague Disease in a comparative coral species framework. Isme J. 2014, 8 (1), 3139,  DOI: 10.1038/ismej.2013.127
  35. 35
    Ben-Haim, Y.; Zicherman-Keren, M.; Rosenberg, E. Temperature-regulated bleaching and lysis of the coral Pocillopora damicornis by the novel pathogen Vibrio coralliilyticus. Appl. Environ. Microbiol. 2003, 69 (7), 42364242,  DOI: 10.1128/AEM.69.7.4236-4242.2003
  36. 36
    Estes, R. M.; Friedman, C. S.; Elston, R. A.; Herwig, R. P. Pathogenicity testing of shellfish hatchery bacterial isolates on Pacific oyster Crassostrea gigas larvae. Dis. Aquat. Org. 2004, 58 (2–3), 223230,  DOI: 10.3354/dao058223
  37. 37
    Manchanayake, T.; Salleh, A.; Amal, M. N. A.; Yasin, I. S. M.; Zamri-Saad, M. Pathology and pathogenesis of Vibrio infection in fish: A review. Aquacult. Rep. 2023, 28, 101459  DOI: 10.1016/j.aqrep.2022.101459
  38. 38
    Vizcaino, M. I.; Johnson, W. R.; Kimes, N. E.; Williams, K.; Torralba, M.; Nelson, K. E.; Smith, G. W.; Weil, E.; Moeller, P. D.; Morris, P. J. Antimicrobial resistance of the coral pathogen Vibrio coralliilyticus and Caribbean sister phylotypes isolated from a diseased octocoral. Microb. Ecol. 2010, 59 (4), 646657,  DOI: 10.1007/s00248-010-9644-3
  39. 39
    Ushijima, B.; Meyer, J. L.; Thompson, S.; Pitts, K.; Marusich, M. F.; Tittl, J.; Weatherup, E.; Reu, J.; Wetzell, R.; Aeby, G. S.; Häse, C. C.; Paul, V. J. Disease Diagnostics and Potential Coinfections by Vibrio coralliilyticus During an Ongoing Coral Disease Outbreak in Florida. Front. Microbiol. 2020, 11, 569354  DOI: 10.3389/fmicb.2020.569354
  40. 40
    Heinz, J. M.; Lu, J.; Huebner, L. K.; Salzberg, S. L.; Sommer, M.; Rosales, S. M. Novel metagenomics analysis of stony coral tissue loss disease bioRxiv: The Preprint Server for Biology 2024  DOI: 10.1101/2024.01.02.573916 .
  41. 41
    Meyer, J. L.; Castellanos-Gell, J.; Aeby, G. S.; Häse, C. C.; Ushijima, B.; Paul, V. J. Microbial Community Shifts Associated With the Ongoing Stony Coral Tissue Loss Disease Outbreak on the Florida Reef Tract. Front. Microbiol. 2019, 10, 2244  DOI: 10.3389/fmicb.2019.02244
  42. 42
    Shilling, E. N.; Combs, I. R.; Voss, J. D. Assessing the effectiveness of two intervention methods for stony coral tissue loss disease on Montastraea cavernosa. Sci. Rep. 2021, 11 (1), 8566  DOI: 10.1038/s41598-021-86926-4
  43. 43
    Studivan, M. S.; Eckert, R. J.; Shilling, E.; Soderberg, N.; Enochs, I. C.; Voss, J. D. Stony coral tissue loss disease intervention with amoxicillin leads to a reversal of disease-modulated gene expression pathways. Mol. Ecol. 2023, 32 (19), 53945413,  DOI: 10.1111/mec.17110
  44. 44
    Rubio-Portillo, E.; Santos, F.; Martínez-García, M.; de Los Ríos, A.; Ascaso, C.; Souza-Egipsy, V.; Ramos-Esplá, A. A.; Anton, J. Structure and temporal dynamics of the bacterial communities associated to microhabitats of the coral Oculina patagonica. Environ. Microbiol. 2016, 18 (12), 45644578,  DOI: 10.1111/1462-2920.13548
  45. 45
    Sunagawa, S.; Coelho, L. P.; Chaffron, S.; Kultima, J. R.; Labadie, K.; Salazar, G.; Djahanschiri, B.; Zeller, G.; Mende, D. R.; Alberti, A.; Cornejo-Castillo, F. M.; Costea, P. I.; Cruaud, C.; d’Ovidio, F.; Engelen, S.; Ferrera, I.; Gasol, J. M.; Guidi, L.; Hildebrand, F.; Kokoszka, F.; Lepoivre, C.; Lima-Mendez, G.; Poulain, J.; Poulos, B. T.; Royo-Llonch, M.; Sarmento, H.; Vieira-Silva, S.; Dimier, C.; Picheral, M.; Searson, S.; Kandels-Lewis, S.; Oceans, T.; Bowler, C.; de Vargas, C.; Gorsky, G.; Grimsley, N.; Hingamp, P.; Iudicone, D.; Jaillon, O.; Not, F.; Ogata, H.; Pesant, S.; Speich, S.; Stemmann, L.; Sullivan, M. B.; Weissenbach, J.; Wincker, P.; Karsenti, E.; Raes, J.; Acinas, S. G.; Bork, P.; Boss, E.; Bowler, C.; Follows, M.; Karp-Boss, L.; Krzic, U.; Reynaud, E. G.; Sardet, C.; Sieracki, M.; Velayoudon, D. Structure and function of the global ocean microbiome. Science 2015, 348 (6237), 1261359  DOI: 10.1126/science.1261359
  46. 46
    Su, H.; Xiao, Z.; Yu, K.; Huang, Q.; Wang, G.; Wang, Y.; Liang, J.; Huang, W.; Huang, X.; Wei, F.; Chen, B. Diversity of cultivable protease-producing bacteria and their extracellular proteases associated to scleractinian corals. PeerJ 2020, 8, e9055  DOI: 10.7717/peerj.9055
  47. 47
    Wei, Y.; Bu, J.; Long, H.; Zhang, X.; Cai, X.; Huang, A.; Ren, W.; Xie, Z. Community Structure of Protease-Producing Bacteria Cultivated From Aquaculture Systems: Potential Impact of a Tropical Environment. Front. Microbiol. 2021, 12, 638129  DOI: 10.3389/fmicb.2021.638129
  48. 48
    Zhou, M.-Y.; Wang, G.-L.; Li, D.; Zhao, D.-L.; Qin, Q.-L.; Chen, X.-L.; Chen, B.; Zhou, B.-C.; Zhang, X.-Y.; Zhang, Y.-Z. Diversity of Both the Cultivable Protease-Producing Bacteria and Bacterial Extracellular Proteases in the Coastal Sediments of King George Island, Antarctica. PLoS One 2013, 8 (11), e79668  DOI: 10.1371/journal.pone.0079668
  49. 49
    Cristóbal, H. A.; López, M. A.; Kothe, E.; Abate, C. M. Diversity of protease-producing marine bacteria from sub-antarctic environments. J. Basic Microbiol. 2011, 51 (6), 590600,  DOI: 10.1002/jobm.201000413
  50. 50
    Zhang, J.; Chen, M.; Huang, J.; Guo, X.; Zhang, Y.; Liu, D.; Wu, R.; He, H.; Wang, J. Diversity of the microbial community and cultivable protease-producing bacteria in the sediments of the Bohai Sea, Yellow Sea and South China Sea. PLoS One 2019, 14 (4), e0215328  DOI: 10.1371/journal.pone.0215328
  51. 51
    Paulsen, S. S.; Strube, M. L.; Bech, P. K.; Gram, L.; Sonnenschein, E. C. Marine Chitinolytic Pseudoalteromonas Represents an Untapped Reservoir of Bioactive Potential. mSystems 2019, 4 (4), e00060-19  DOI: 10.1128/mSystems.00060-19
  52. 52
    Cimermancic, P.; Medema, M. H.; Claesen, J.; Kurita, K.; Brown, L. C. W.; Mavrommatis, K.; Pati, A.; Godfrey, P. A.; Koehrsen, M.; Clardy, J.; Birren, B. W.; Takano, E.; Sali, A.; Linington, R. G.; Fischbach, M. A. Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell 2014, 158 (2), 412421,  DOI: 10.1016/j.cell.2014.06.034
  53. 53
    Buijs, Y.; Bech, P. K.; Vazquez-Albacete, D.; Bentzon-Tilia, M.; Sonnenschein, E. C.; Gram, L.; Zhang, S.-D. Marine Proteobacteria as a source of natural products: advances in molecular tools and strategies. Nat. Prod. Rep. 2019, 36 (9), 13331350,  DOI: 10.1039/C9NP00020H
  54. 54
    Baba, A.; Miyazaki, M.; Nagahama, T.; Nogi, Y. Microbulbifer chitinilyticus sp. nov. and Microbulbifer okinawensis sp. nov., chitin-degrading bacteria isolated from mangrove forests. Int. J. Syst. Evol. Microbiol. 2011, 61 (Pt 9), 22152220,  DOI: 10.1099/ijs.0.024158-0
  55. 55
    Miyazaki, M.; Nogi, Y.; Ohta, Y.; Hatada, Y.; Fujiwara, Y.; Ito, S.; Horikoshi, K. Microbulbifer agarilyticus sp. nov. and Microbulbifer thermotolerans sp. nov., agar-degrading bacteria isolated from deep-sea sediment. Int. J. Syst. Evol. Microbiol. 2008, 58, 11281133,  DOI: 10.1099/ijs.0.65507-0
  56. 56
    Vashist, P.; Nogi, Y.; Ghadi, S. C.; Verma, P.; Shouche, Y. S. Microbulbifer mangrovi sp. nov., a polysaccharide-degrading bacterium isolated from an Indian mangrove. Int. J. Syst. Evol. Microbiol. 2013, 63, 25322537,  DOI: 10.1099/ijs.0.042978-0
  57. 57
    González, J. M.; Mayer, F.; Moran, M. A.; Hodson, R. E.; Whitman, W. B. Microbulbifer hydrolyticus gen. nov., sp. nov., and Marinobacterium georgiense gen. nov., sp. nov., two marine bacteria from a lignin-rich pulp mill waste enrichment community. Int. J. Syst. Bacteriol. 1997, 47 (2), 369376,  DOI: 10.1099/00207713-47-2-369
  58. 58
    Lee, Y. S. Isolation and Characterization of a Novel Cold-Adapted Esterase, MtEst45, from Microbulbifer thermotolerans DAU221. Front. Microbiol. 2016, 7, 218  DOI: 10.3389/fmicb.2016.00218
  59. 59
    Jayanetti, D. R.; Braun, D. R.; Barns, K. J.; Rajski, S. R.; Bugni, T. S. Bulbiferates A and B: Antibacterial Acetamidohydroxybenzoates from a Marine Proteobacterium, Microbulbifer sp. J. Nat. Prod. 2019, 82 (7), 19301934,  DOI: 10.1021/acs.jnatprod.9b00312
  60. 60
    Lu, S.; Zhang, Z.; Sharma, A. R.; Nakajima-Shimada, J.; Harunari, E.; Oku, N.; Trianto, A.; Igarashi, Y. Bulbiferamide, an Antitrypanosomal Hexapeptide Cyclized via an N-Acylindole Linkage from a Marine Obligate Microbulbifer. J. Nat. Prod. 2023, 86 (4), 10811086,  DOI: 10.1021/acs.jnatprod.2c01083
  61. 61
    Zhong, W.; Deutsch, J. M.; Yi, D.; Abrahamse, N. H.; Mohanty, I.; Moore, S. G.; McShan, A. C.; Garg, N.; Agarwal, V. Discovery and Biosynthesis of Ureidopeptide Natural Products Macrocyclized via Indole N-acylation in Marine Microbulbifer spp. Bacteria. ChemBioChem 2023, 24 (12), e202300190  DOI: 10.1002/cbic.202300190
  62. 62
    Zhong, W.; Aiosa, N.; Deutsch, J. M.; Garg, N.; Agarwal, V. Pseudobulbiferamides: Plasmid-Encoded Ureidopeptide Natural Products with Biosynthetic Gene Clusters Shared Among Marine Bacteria of Different Genera. J. Nat. Prod. 2023, 86 (10), 24142420,  DOI: 10.1021/acs.jnatprod.3c00595
  63. 63
    Zhong, W.; Agarwal, V. Polymer degrading marine Microbulbifer bacteria: an un(der)utilized source of chemical and biocatalytic novelty. Beilstein J. Org. Chem. 2024, 20, 16351651,  DOI: 10.3762/bjoc.20.146
  64. 64
    Mawji, E.; Gledhill, M.; Milton, J. A.; Tarran, G. A.; Ussher, S.; Thompson, A.; Wolff, G. A.; Worsfold, P. J.; Achterberg, E. P. Hydroxamate siderophores: occurrence and importance in the Atlantic Ocean. Environ. Sci. Technol. 2008, 42 (23), 86758680,  DOI: 10.1021/es801884r
  65. 65
    Boiteau, R. M.; Mende, D. R.; Hawco, N. J.; McIlvin, M. R.; Fitzsimmons, J. N.; Saito, M. A.; Sedwick, P. N.; DeLong, E. F.; Repeta, D. J. Siderophore-Based Microbial Adaptations to Iron Scarcity Across the Eastern Pacific Ocean. Proc. Natl. Acad. Sci. U.S.A. 2016, 113 (50), 1423714242,  DOI: 10.1073/pnas.1608594113
  66. 66
    Deutsch, J. M.; Green, M. O.; Akavaram, P.; Davis, A. C.; Diskalkar, S. S.; Du Plessis, I. A.; Fallon, H. A.; Grason, E. M.; Kauf, E. G.; Kim, Z. M.; Miller, J. R.; Neal, A. L.; Riera, T.; Stroeva, S.-E.; Tran, J.; Tran, V.; Coronado, A. V.; Coronado, V. V.; Wall, B. T.; Yang, Cm.; Mohanty, I.; Abrahamse, N. H.; Freeman, C. J.; Easson, C. G.; Fiore, C. L.; Onstine, A. E.; Djeddar, N.; Biliya, S.; Bryksin, A. V.; Garg, N.; Agarwal, V. Limited Metabolomic Overlap between Commensal Bacteria and Marine Sponge Holobionts Revealed by Large Scale Culturing and Mass Spectrometry-Based Metabolomics: An Undergraduate Laboratory Pedagogical Effort at Georgia Tech. Mar. Drugs 2023, 21 (1), 53  DOI: 10.3390/md21010053
  67. 67
    Buijs, Y.; Isbrandt, T.; Zhang, S.-D.; Larsen, T. O.; Gram, L. The Antibiotic Andrimid Produced by Vibrio coralliilyticus Increases Expression of Biosynthetic Gene Clusters and Antibiotic Production in Photobacterium galatheae. Front. Microbiol. 2020, 11, 622055  DOI: 10.3389/fmicb.2020.622055
  68. 68
    Pluskal, T.; Castillo, S.; Villar-Briones, A.; Orešič, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinf. 2010, 11 (1), 395  DOI: 10.1186/1471-2105-11-395
  69. 69
    Wang, M.; Carver, J. J.; Phelan, V. V.; Sanchez, L. M.; Garg, N.; Peng, Y.; Nguyen, D. D.; Watrous, J.; Kapono, C. A.; Luzzatto-Knaan, T.; Porto, C.; Bouslimani, A.; Melnik, A. V.; Meehan, M. J.; Liu, W.-T.; Crüsemann, M.; Boudreau, P. D.; Esquenazi, E.; Sandoval-Calderón, M.; Kersten, R. D.; Pace, L. A.; Quinn, R. A.; Duncan, K. R.; Hsu, C.-C.; Floros, D. J.; Gavilan, R. G.; Kleigrewe, K.; Northen, T.; Dutton, R. J.; Parrot, D.; Carlson, E. E.; Aigle, B.; Michelsen, C. F.; Jelsbak, L.; Sohlenkamp, C.; Pevzner, P.; Edlund, A.; McLean, J.; Piel, J.; Murphy, B. T.; Gerwick, L.; Liaw, C.-C.; Yang, Y.-L.; Humpf, H.-U.; Maansson, M.; Keyzers, R. A.; Sims, A. C.; Johnson, A. R.; Sidebottom, A. M.; Sedio, B. E.; Klitgaard, A.; Larson, C. B.; Boya P, C. A.; Torres-Mendoza, D.; Gonzalez, D. J.; Silva, D. B.; Marques, L. M.; Demarque, D. P.; Pociute, E.; O’Neill, E. C.; Briand, E.; Helfrich, E. J. N.; Granatosky, E. A.; Glukhov, E.; Ryffel, F.; Houson, H.; Mohimani, H.; Kharbush, J. J.; Zeng, Y.; Vorholt, J. A.; Kurita, K. L.; Charusanti, P.; McPhail, K. L.; Nielsen, K. F.; Vuong, L.; Elfeki, M.; Traxler, M. F.; Engene, N.; Koyama, N.; Vining, O. B.; Baric, R.; Silva, R. R.; Mascuch, S. J.; Tomasi, S.; Jenkins, S.; Macherla, V.; Hoffman, T.; Agarwal, V.; Williams, P. G.; Dai, J.; Neupane, R.; Gurr, J.; Rodríguez, A. M. C.; Lamsa, A.; Zhang, C.; Dorrestein, K.; Duggan, B. M.; Almaliti, J.; Allard, P.-M.; Phapale, P.; Nothias, L.-F.; Alexandrov, T.; Litaudon, M.; Wolfender, J.-L.; Kyle, J. E.; Metz, T. O.; Peryea, T.; Nguyen, D.-T.; VanLeer, D.; Shinn, P.; Jadhav, A.; Müller, R.; Waters, K. M.; Shi, W.; Liu, X.; Zhang, L.; Knight, R.; Jensen, P. R.; Palsson, B. Ø.; Pogliano, K.; Linington, R. G.; Gutiérrez, M.; Lopes, N. P.; Gerwick, W. H.; Moore, B. S.; Dorrestein, P. C.; Bandeira, N. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34 (8), 828837,  DOI: 10.1038/nbt.3597
  70. 70
    Shannon, P.; Markie, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 24982504,  DOI: 10.1101/gr.1239303
  71. 71
    Khan, A.; Mathelier, A. Intervene: a tool for intersection and visualization of multiple gene or genomic region sets. BMC Bioinf. 2017, 18 (1), 287  DOI: 10.1186/s12859-017-1708-7
  72. 72
    Dührkop, K.; Fleischauer, M.; Ludwig, M.; Aksenov, A. A.; Melnik, A. V. SIRIUS 4: A Rapid Tool for Turning Tandem Mass Spectra into Metabolite Structure Information. Nat. Methods 2019, 16, 299302,  DOI: 10.1038/s41592-019-0344-8
  73. 73
    Dührkop, K.; Nothias, L.-F.; Fleischauer, M.; Reher, R.; Ludwig, M.; Hoffmann, M. A.; Petras, D.; Gerwick, W. H.; Rousu, J.; Dorrestein, P. C.; Böcker, S. Systematic Classification of Unknown Metabolites Using High-Resolution Fragmentation Mass Spectra. Nat. Biotechnol. 2021, 39, 462471,  DOI: 10.1038/s41587-020-0740-8
  74. 74
    van der Hooft, J. J. J.; Wandy, J.; Barrett, M. P.; Burgess, K. E. V.; Rogers, S. Topic modeling for untargeted substructure exploration in metabolomics. Proc. Natl. Acad. Sci. U.S.A. 2016, 113 (48), 1373813743,  DOI: 10.1073/pnas.1608041113
  75. 75
    van Santen, J. A.; Jacob, G.; Singh, A. L.; Aniebok, V.; Balunas, M. J.; Bunsko, D.; Neto, F. C.; Castaño-Espriu, L.; Chang, C.; Clark, T. N.; Cleary Little, J. L.; Delgadillo, D. A.; Dorrestein, P. C.; Duncan, K. R.; Egan, J. M.; Galey, M. M.; Haeckl, F. P. J.; Hua, A.; Hughes, A. H.; Iskakova, D.; Khadilkar, A.; Lee, J.-H.; Lee, S.; LeGrow, N.; Liu, D. Y.; Macho, J. M.; McCaughey, C. S.; Medema, M. H.; Neupane, R. P.; O’Donnell, T. J.; Paula, J. S.; Sanchez, L. M.; Shaikh, A. F.; Soldatou, S.; Terlouw, B. R.; Tran, T. A.; Valentine, M.; van der Hooft, J. J. J.; Vo, D. A.; Wang, M.; Wilson, D.; Zink, K. E.; Linington, R. G. The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery. ACS Cent. Sci. 2019, 5 (11), 18241833,  DOI: 10.1021/acscentsci.9b00806
  76. 76
    MarinLit. A Database of the Marine Natural Products Literature, Royal Society of Chemistry http://pubs.rsc.org/marinlit/. (accessed January 20, 2023).
  77. 77
    Al Shaer, D.; Al Musaimi, O.; de la Torre, B. G.; Albericio, F. Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens. Eur. J. Med. Chem. 2020, 208, 112791  DOI: 10.1016/j.ejmech.2020.112791
  78. 78
    Martinez, J. S.; Carter-Franklin, J. N.; Mann, E. L.; Martin, J. D.; Haygood, M. G.; Butler, A. Structure and membrane affinity of a suite of amphiphilic siderophores produced by a marine bacterium. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7), 37543759,  DOI: 10.1073/pnas.0637444100
  79. 79
    Walker, L. R.; Tfaily, M. M.; Shaw, J. B.; Hess, N. J.; Paša-Tolić, L.; Koppenaal, D. W. Unambiguous identification and discovery of bacterial siderophores by direct injection 21 T Fourier transform ion cyclotron resonance mass spectrometry. Metallomics 2017, 9 (1), 8292,  DOI: 10.1039/C6MT00201C
  80. 80
    Pérez-Miranda, S.; Cabirol, N.; George-Téllez, R.; Zamudio-Rivera, L. S.; Fernández, F. J. O-CAS, a fast and universal method for siderophore detection. J. Microbiol. Methods 2007, 70 (1), 127131,  DOI: 10.1016/j.mimet.2007.03.023
  81. 81
    Raines, D. J.; Sanderson, T. J.; Wilde, E. J.; Duhme-Klair, A. K. Siderophores. In Reference Module in Chemistry, Molecular Sciences and Chemical Engineering; Elsevier, 2015.
  82. 82
    Hou, Z.; Raymond, K. N.; O’Sulliva, B.; Esker, T. W.; Nishio, T. A Preorganized Siderophore: Thermodynamic and Structural Characterization of Alcaligin and Bisucaberin, Microbial Macrocyclic Dihydroxamate Chelating Agents1. Inorg. Chem. 1998, 37 (26), 66306637,  DOI: 10.1021/ic9810182
  83. 83
    Harris, W. R.; Carrano, C. J.; Raymond, K. N. Coordination chemistry of microbial iron transport compounds. 16. Isolation, characterization, and formation constants of ferric aerobactin. J. Am. Chem. Soc. 1979, 101 (10), 27222727,  DOI: 10.1021/ja00504a038
  84. 84
    Ito, T.; Neilands, J. B. Products of “Low-iron Fermentation” with Bacillus subilis: Isolation, Characterization and Synthesis of 2,3-Dihydroxybenzoylglycine1,2. J. Am. Chem. Soc. 1958, 80 (17), 46454647,  DOI: 10.1021/ja01550a058
  85. 85
    Barghouthi, S.; Young, R.; Olson, M. O.; Arceneaux, J. E.; Clem, L. W.; Byers, B. R. Amonabactin, a novel tryptophan- or phenylalanine-containing phenolate siderophore in Aeromonas hydrophila. J. Bacteriol. 1989, 171 (4), 18111816,  DOI: 10.1128/jb.171.4.1811-1816.1989
  86. 86
    Atkin, C. L.; Neilands, J. B. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry 1968, 7 (10), 37343739,  DOI: 10.1021/bi00850a054
  87. 87
    Spasojević, I.; Boukhalfa, H.; Stevens, R. D.; Crumbliss, A. L. Aqueous Solution Speciation of Fe(III) Complexes with Dihydroxamate Siderophores Alcaligin and Rhodotorulic Acid and Synthetic Analogues Using Electrospray Ionization Mass Spectrometry. Inorg. Chem. 2001, 40 (1), 4958,  DOI: 10.1021/ic991390x
  88. 88
    Xu, G.; Martinez, J. S.; Groves, J. T.; Butler, A. Membrane Affinity of the Amphiphilic Marinobactin Siderophores. J. Am. Chem. Soc. 2002, 124 (45), 1340813415,  DOI: 10.1021/ja026768w
  89. 89
    Harrington, J. M.; Crumbliss, A. L. The redox hypothesis in siderophore-mediated iron uptake. BioMetals 2009, 22 (4), 679689,  DOI: 10.1007/s10534-009-9233-4
  90. 90
    Schalk, I. J.; Guillon, L. Fate of ferrisiderophores after import across bacterial outer membranes: different iron release strategies are observed in the cytoplasm or periplasm depending on the siderophore pathways. Amino Acids 2013, 44 (5), 12671277,  DOI: 10.1007/s00726-013-1468-2
  91. 91
    Miethke, M.; Marahiel, M. A. Siderophore-Based Iron Acquisition and Pathogen Control. Microbiol. Mol. Biol. Rev. 2007, 71 (3), 413451,  DOI: 10.1128/MMBR.00012-07
  92. 92
    Greenwood, K. T.; Luke, R. K. J. Enzymatic hydrolysis of enterochelin and its iron complex in Escherichia coli K-12. Properties of enterochelin esterase. Biochim. Biophys. Acta, Enzymol. 1978, 525 (1), 209218,  DOI: 10.1016/0005-2744(78)90216-4
  93. 93
    Langman, L.; Young, I. G.; Frost, G. E.; Rosenberg, H.; Gibson, F. Enterochelin system of iron transport in Escherichia coli: mutations affecting ferric-enterochelin esterase. J. Bacteriol. 1972, 112 (3), 11421149,  DOI: 10.1128/jb.112.3.1142-1149.1972
  94. 94
    O’Brien, I. G.; Cox, G. B.; Gibson, F. Enterochelin hydrolysis and iron metabolism in Escherichia coli. Biochim. Biophys. Acta, Gen. Subj. 1971, 237 (3), 537549,  DOI: 10.1016/0304-4165(71)90274-1
  95. 95
    Lin, H.; Fischbach, M. A.; Liu, D. R.; Walsh, C. T. In Vitro Characterization of Salmochelin and Enterobactin Trilactone Hydrolases IroD, IroE, and Fes. J. Am. Chem. Soc. 2005, 127 (31), 1107511084,  DOI: 10.1021/ja0522027
  96. 96
    Miethke, M.; Klotz, O.; Linne, U.; May, J. J.; Beckering, C. L.; Marahiel, M. A. Ferri-bacillibactin uptake and hydrolysis in Bacillus subtilis. Mol. Microbiol. 2006, 61 (6), 14131427,  DOI: 10.1111/j.1365-2958.2006.05321.x
  97. 97
    Abergel, R. J.; Zawadzka, A. M.; Hoette, T. M.; Raymond, K. N. Enzymatic Hydrolysis of Trilactone Siderophores: Where Chiral Recognition Occurs in Enterobactin and Bacillibactin Iron Transport. J. Am. Chem. Soc. 2009, 131 (35), 1268212692,  DOI: 10.1021/ja903051q
  98. 98
    Ecker, F.; Haas, H.; Groll, M.; Huber, E. M. Iron Scavenging in Aspergillus Species: Structural and Biochemical Insights into Fungal Siderophore Esterases. Angew. Chem., Int. Ed. 2018, 57 (44), 1462414629,  DOI: 10.1002/anie.201807093
  99. 99
    Gründlinger, M.; Gsaller, F.; Schrettl, M.; Lindner, H.; Haas, H. Aspergillus fumigatus SidJ mediates intracellular siderophore hydrolysis. Appl. Environ. Microbiol. 2013, 79 (23), 75347536,  DOI: 10.1128/AEM.01285-13
  100. 100
    Kragl, C.; Schrettl, M.; Abt, B.; Sarg, B.; Lindner, H. H.; Haas, H. EstB-mediated hydrolysis of the siderophore triacetylfusarinine C optimizes iron uptake of Aspergillus fumigatus. Eukaryotic Cell 2007, 6 (8), 12781285,  DOI: 10.1128/EC.00066-07
  101. 101
    Winkelmann, G.; Schmidtkunz, K.; Rainey, F. A. Characterization of a novel Spirillum-like bacterium that degrades ferrioxamine-type siderophores. BioMetals 1996, 9 (1), 7883,  DOI: 10.1007/BF00188094
  102. 102
    Winkelmann, G.; Busch, B.; Hartmann, A.; Kirchhof, G.; Süssmuth, R.; Jung, G. Degradation of desferrioxamines by Azospirillum irakense: assignment of metabolites by HPLC/electrospray mass spectrometry. BioMetals 1999, 12 (3), 255264,  DOI: 10.1023/A:1009242307134
  103. 103
    Pierwola, A.; Krupinski, T.; Zalupski, P.; Chiarelli, M.; Castignetti, D. Degradation Pathway and Generation of Monohydroxamic Acids from the Trihydroxamate Siderophore Deferrioxamine B. Appl. Environ. Microbiol. 2004, 70 (2), 831836,  DOI: 10.1128/AEM.70.2.831-836.2004
  104. 104
    DeAngelis, R.; Forsyth, M.; Castignetti, D. The nutritional selectivity of a siderophore-catabolizing bacterium. BioMetals 1993, 6 (4), 234238,  DOI: 10.1007/BF00187761
  105. 105
    Castignetti, D.; Siddiqui, A. S. The catabolism and heterotrophic nitrification of the siderophore deferrioxamine B. Biol. Met. 1990, 3 (3–4), 197203,  DOI: 10.1007/BF01140579
  106. 106
    Sanchez, N.; Peterson, C. K.; Gonzalez, S. V.; Vadstein, O.; Olsen, Y.; Ardelan, M. V. Effect of hydroxamate and catecholate siderophores on iron availability in the diatom Skeletonema costatum: Implications of siderophore degradation by associated bacteria. Mar. Chem. 2019, 209, 107119,  DOI: 10.1016/j.marchem.2019.01.005
  107. 107
    French, K. S.; Chukwuma, E.; Linshitz, I.; Namba, K.; Duckworth, O. W.; Cubeta, M. A.; Baars, O. Inactivation of siderophore iron-chelating moieties by the fungal wheat root symbiont Pyrenophora biseptata. Environ. Microbiol. Rep. 2024, 16 (1), e13234  DOI: 10.1111/1758-2229.13234
  108. 108
    Villavicencio, M.; Neilands, J. B. An inducible ferrichrome A-degrading peptidase from Pseudomonas FC-1. Biochemistry 1965, 4 (6), 10921097,  DOI: 10.1021/bi00882a017
  109. 109
    Warren, R. A. J.; Neilands, J. B. Microbial degradation of the ferrichrome compounds. J. Gen. Microbiol. 1964, 35, 459470,  DOI: 10.1099/00221287-35-3-459
  110. 110
    Warren, R. A.; Neilands, J. B. Mechanism of microbial catabolism of ferrichrome A. J. Biol. Chem. 1965, 240, 20552058,  DOI: 10.1016/S0021-9258(18)97424-7
  111. 111
    Hider, R. C.; Kong, X. Chemistry and biology of siderophores. Nat. Prod. Rep. 2010, 27 (5), 637657,  DOI: 10.1039/b906679a
  112. 112
    Kaipanchery, V.; Sharma, A.; Albericio, F.; de la Torre, B. G. Insights into the chemistry of the amphibactin–metal (M3+) interaction and its role in antibiotic resistance. Sci. Rep. 2020, 10 (1), 21049  DOI: 10.1038/s41598-020-77807-3
  113. 113
    Dhungana, S.; Crumbliss, A. L. Coordination Chemistry and Redox Processes in Siderophore-Mediated Iron Transport. Geomicrobiol. J. 2005, 22 (3–4), 8798,  DOI: 10.1080/01490450590945870
  114. 114
    Gauglitz, J. M.; Iinishi, A.; Ito, Y.; Butler, A. Microbial Tailoring of Acyl Peptidic Siderophores. Biochemistry 2014, 53 (16), 26242631,  DOI: 10.1021/bi500266x
  115. 115
    Perraud, Q.; Moynié, L.; Gasser, V.; Munier, M.; Godet, J.; Hoegy, F.; Mély, Y.; Mislin, G. L. A.; Naismith, J. H.; Schalk, I. J. A Key Role for the Periplasmic PfeE Esterase in Iron Acquisition via the Siderophore Enterobactin in Pseudomonas aeruginosa. ACS Chem. Biol. 2018, 13 (9), 26032614,  DOI: 10.1021/acschembio.8b00543
  116. 116
    Zeng, X.; Mo, Y.; Xu, F.; Lin, J. Identification and characterization of a periplasmic trilactone esterase, Cee, revealed unique features of ferric enterobactin acquisition in Campylobacter. Mol. Microbiol. 2013, 87 (3), 594608,  DOI: 10.1111/mmi.12118
  117. 117
    Noinaj, N.; Guillier, M.; Barnard, T. J.; Buchanan, S. K. TonB-dependent transporters: regulation, structure, and function. Annu. Rev. Microbiol. 2010, 64, 4360,  DOI: 10.1146/annurev.micro.112408.134247
  118. 118
    Rivera, M. Bacterioferritin: Structure, Dynamics, and Protein–Protein Interactions at Play in Iron Storage and Mobilization. Acc. Chem. Res. 2017, 50 (2), 331340,  DOI: 10.1021/acs.accounts.6b00514
  119. 119
    Kramer, J.; Özkaya, Ö.; Kümmerli, R. Bacterial siderophores in community and host interactions. Nat. Rev. Microbiol. 2020, 18 (3), 152163,  DOI: 10.1038/s41579-019-0284-4
  120. 120
    Barber, M. F.; Elde, N. C. Buried Treasure: Evolutionary Perspectives on Microbial Iron Piracy. Trends Genet. 2015, 31 (11), 627636,  DOI: 10.1016/j.tig.2015.09.001
  121. 121
    Gauglitz, J. M.; Boiteau, R. M.; McLean, C.; Babcock-Adams, L.; McIlvin, M. R.; Moran, D. M.; Repeta, D. J.; Saito, M. A. Dynamic proteome response of a marine Vibrio to a gradient of iron and ferrioxamine bioavailability. Mar. Chem. 2021, 229, 103913  DOI: 10.1016/j.marchem.2020.103913
  122. 122
    Thode, S. K.; Rojek, E.; Kozlowski, M.; Ahmad, R.; Haugen, P. Distribution of siderophore gene systems on a Vibrionaceae phylogeny: Database searches, phylogenetic analyses and evolutionary perspectives. PLoS One 2018, 13 (2), e0191860  DOI: 10.1371/journal.pone.0191860
  123. 123
    Eickhoff, M. J.; Bassler, B. L. Vibrio fischeri siderophore production drives competitive exclusion during dual-species growth. Mol. Microbiol. 2020, 114 (2), 244261,  DOI: 10.1111/mmi.14509
  124. 124
    González, J. M.; Mayer, F.; Moran, M. A.; Hodson, R. E.; Whitman, W. B. Microbulbifer hydrolyticus gen. nov., sp. nov., and Marinobacterium georgiense gen. nov., sp. nov., Two Marine Bacteria from a Lignin-Rich Pulp Mill Waste Enrichment Community. Int. J. Syst. Bacteriol. 1997, 47 (2), 369376,  DOI: 10.1099/00207713-47-2-369
  125. 125
    Williamson, N. R.; Fineran, P. C.; Gristwood, T.; Chawrai, S. R.; Leeper, F. J.; Salmond, G. P. Anticancer and immunosuppressive properties of bacterial prodiginines. Future Microbiol. 2007, 2 (6), 605618,  DOI: 10.2217/17460913.2.6.605
  126. 126
    Nguyen, S. L. T.; Nguyen, T. C.; Do, T. T.; Vu, T. L.; Nguyen, T. T.; Do, T. T.; Nguyen, T. H. T.; Le, T. H.; Trinh, D. K.; Nguyen, T. A. T. Study on the Anticancer Activity of Prodigiosin from Variants of Serratia Marcescens QBN VTCC 910026. BioMed Res. Int. 2022, 2022 (1), 4053074  DOI: 10.1155/2022/4053074
  127. 127
    Danevčič, T.; Borić Vezjak, M.; Zorec, M.; Stopar, D. Prodigiosin - A Multifaceted Escherichia coli Antimicrobial Agent. PLoS One 2016, 11 (9), e0162412  DOI: 10.1371/journal.pone.0162412
  128. 128
    Arivuselvam, R.; Dera, A. A.; Parween Ali, S.; Alraey, Y.; Saif, A.; Hani, U.; Ramakrishnan, S. A.; Azeeze, M.; Rajeshkumar, R.; Susil, A.; Harindranath, H.; Kumar, B. R. P. Isolation, Identification, and Antibacterial Properties of Prodigiosin, a Bioactive Product Produced by a New Serratia marcescens JSSCPM1 Strain: Exploring the Biosynthetic Gene Clusters of Serratia Species for Biological Applications. Antibiotics 2023, 12 (9), 1466  DOI: 10.3390/antibiotics12091466
  129. 129
    Kim, H. J.; Lee, M.-S.; Jeong, S. K.; Lee, S. J. Transcriptomic analysis of the antimicrobial activity of prodigiosin against Cutibacterium acnes. Sci. Rep. 2023, 13 (1), 17412  DOI: 10.1038/s41598-023-44612-7
  130. 130
    Zhang, H.; Peng, Y.; Zhang, S.; Cai, G.; Li, Y.; Yang, X.; Yang, K.; Chen, Z.; Zhang, J.; Wang, H.; Zheng, T.; Zheng, W. Algicidal Effects of Prodigiosin on the Harmful Algae Phaeocystis globosa. Front. Microbiol. 2016, 7, 602  DOI: 10.3389/fmicb.2016.00602
  131. 131
    Yang, K.; Chen, Q.; Zhang, D.; Zhang, H.; Lei, X.; Chen, Z.; Li, Y.; Hong, Y.; Ma, X.; Zheng, W.; Tian, Y.; Zheng, T.; Xu, H. The algicidal mechanism of prodigiosin from Hahella sp. KA22 against Microcystis aeruginosa. Sci. Rep. 2017, 7 (1), 7750  DOI: 10.1038/s41598-017-08132-5
  132. 132
    Gomez Valdez, L.; Rondan Dueñas, J. C.; Andrade, A. J.; Del Valle, E. E.; Doucet, M. E.; Lax, P. In vitro and in vivo nematicidal activity of prodigiosin against the plant-parasitic nematode Nacobbus celatus. Biocontrol Sci. Technol. 2022, 32 (6), 741751,  DOI: 10.1080/09583157.2022.2045474
  133. 133
    Longeon, A.; Copp, B. R.; Quévrain, E.; Roué, M.; Kientz, B.; Cresteil, T.; Petek, S.; Debitus, C.; Bourguet-Kondracki, M.-L. Bioactive Indole Derivatives from the South Pacific Marine Sponges Rhopaloeides odorabile and Hyrtios sp. Mar. Drugs 2011, 9 (5), 879888,  DOI: 10.3390/md9050879
  134. 134
    Miguel-Gordo, M.; Gegunde, S.; Calabro, K.; Jennings, L. K.; Alfonso, A.; Genta-Jouve, G.; Vacelet, J.; Botana, L. M.; Thomas, O. P. Bromotryptamine and Bromotyramine Derivatives from the Tropical Southwestern Pacific Sponge Narrabeena nigra. Mar. Drugs 2019, 17 (6), 319  DOI: 10.3390/md17060319
  135. 135
    Peters, L.; König, G. M.; Terlau, H.; Wright, A. D. Four New Bromotryptamine Derivatives from the Marine Bryozoan Flustra foliacea. J. Nat. Prod. 2002, 65 (11), 16331637,  DOI: 10.1021/np0105984
  136. 136
    Di, X.; Wang, S.; Oskarsson, J. T.; Rouger, C.; Tasdemir, D.; Hardardottir, I.; Freysdottir, J.; Wang, X.; Molinski, T. F.; Omarsdottir, S. Bromotryptamine and Imidazole Alkaloids with Anti-inflammatory Activity from the Bryozoan Flustra foliacea. J. Nat. Prod. 2020, 83 (10), 28542866,  DOI: 10.1021/acs.jnatprod.0c00126
  137. 137
    Simmons, T. L.; Coates, R. C.; Clark, B. R.; Engene, N.; Gonzalez, D.; Esquenazi, E.; Dorrestein, P. C.; Gerwick, W. H. Biosynthetic origin of natural products isolated from marine microorganism–invertebrate assemblages. Proc. Natl. Acad. Sci. U.S.A. 2008, 105 (12), 45874594,  DOI: 10.1073/pnas.0709851105
  138. 138
    Ding, L.; He, S.; Wu, W.; Jin, H.; Zhu, P.; Zhang, J.; Wang, T.; Yuan, Y.; Yan, X. Discovery and Structure-Based Optimization of 6-Bromotryptamine Derivatives as Potential 5-HT2A Receptor Antagonists. Molecules 2015, 20 (9), 1767517683,  DOI: 10.3390/molecules200917675
  139. 139
    Diep, C. N.; Lyakhova, E. G.; Berdyshev, D. V.; Kalinovsky, A. I.; Tu, V. A.; Cuong, N. X.; Nam, N. H.; Minh, C. V.; Stonik, V. A. Structures and absolute stereochemistry of guaiane sesquiterpenoids from the gorgonian Menella woodin. Tetrahedron Lett. 2015, 56 (50), 70017004,  DOI: 10.1016/j.tetlet.2015.10.102
  140. 140
    Phan, C.-S.; Kamada, T.; Ishii, T.; Hamada, T.; Vairappan, C. S. A New Guaiane-type Sesquiterpenoid from a Bornean Soft Coral, Xenia stellifera. Nat. Prod. Commun. 2018, 13, 1934578X1801300105  DOI: 10.1177/1934578x1801300105
  141. 141
    Kozawa, S.; Ishiyama, H.; Fromont, J.; Kobayashi, J. Halichonadin E, a Dimeric Sesquiterpenoid from the Sponge Halichondria sp. J. Nat. Prod. 2008, 71 (3), 445447,  DOI: 10.1021/np0703139
  142. 142
    Drew, D. P.; Krichau, N.; Reichwald, K.; Simonsen, H. T. Guaianolides in apiaceae: perspectives on pharmacology and biosynthesis. Phytochem. Rev. 2009, 8 (3), 581599,  DOI: 10.1007/s11101-009-9130-z
  143. 143
    Li, X.-W.; Weng, L.; Gao, X.; Zhao, Y.; Pang, F.; Liu, J.-H.; Zhang, H.-F.; Hu, J.-F. Antiproliferative and apoptotic sesquiterpene lactones from Carpesium faberi. Bioorg. Med. Chem. Lett. 2011, 21 (1), 366372,  DOI: 10.1016/j.bmcl.2010.10.138
  144. 144
    Wang, S.; Sun, J.; Zeng, K.; Chen, X.; Zhou, W.; Zhang, C.; Jin, H.; Jiang, Y.; Tu, P. Sesquiterpenes from Artemisia argyi: Absolute Configurations and Biological Activities. Eur. J. Org. Chem. 2014, 2014 (5), 973983,  DOI: 10.1002/ejoc.201301445
  145. 145
    Yuuya, S.; Hagiwara, H.; Suzuki, T.; Ando, M.; Yamada, A.; Suda, K.; Kataoka, T.; Nagai, K. Guaianolides as immunomodulators. Synthesis and biological activities of dehydrocostus lactone, mokko lactone, eremanthin, and their derivatives. J. Nat. Prod. 1999, 62 (1), 2230,  DOI: 10.1021/np980092u
  146. 146
    De Toledo, J. S.; Ambrósio, S. R.; Borges, C. H. G.; Manfrim, V.; Cerri, D. G.; Cruz, A. K.; Da Costa, F. B. In Vitro Leishmanicidal Activities of Sesquiterpene Lactones from Tithonia diversifolia against Leishmania braziliensis Promastigotes and Amastigotes. Molecules 2014, 19 (5), 60706079,  DOI: 10.3390/molecules19056070
  147. 147
    Niu, S.; Xie, C.-L.; Xia, J.-M.; Luo, Z.-H.; Shao, Z.; Yang, X.-W. New anti-inflammatory guaianes from the Atlantic hydrotherm-derived fungus Graphostroma sp. MCCC 3A00421. Sci. Rep. 2018, 8 (1), 530  DOI: 10.1038/s41598-017-18841-6
  148. 148
    Chakraborty, K.; Lipton, A. P.; Paulraj, R.; Chakraborty, R. D. Guaiane sesquiterpenes from seaweed Ulva fasciata Delile and their antibacterial properties. Eur. J. Med. Chem. 2010, 45 (6), 22372244,  DOI: 10.1016/j.ejmech.2010.01.065
  149. 149
    Zhou, L.; Chen, B.; Zhang, Y.; Zhang, X.; Li, X.; Wang, C. New Anti-HSV-1 Guaiane Lactone from Hainan Gorgonian Echinomuricea indomalaccensis. J. Ocean Univ. China 2022, 21 (4), 965968,  DOI: 10.1007/s11802-022-4878-y
  150. 150
    Battista, N.; Bari, M.; Bisogno, T. N-Acyl Amino Acids: Metabolism, Molecular Targets, and Role in Biological Processes. Biomolecules 2019, 9 (12), 822  DOI: 10.3390/biom9120822
  151. 151
    Burstein, S. The elmiric acids: Biologically active anandamide analogs. Neuropharmacology 2008, 55 (8), 12591264,  DOI: 10.1016/j.neuropharm.2007.11.011
  152. 152
    Cani, P. D.; Plovier, H.; Van Hul, M.; Geurts, L.; Delzenne, N. M.; Druart, C.; Everard, A. Endocannabinoids ─ at the crossroads between the gut microbiota and host metabolism. Nat. Rev. Endocrinol. 2016, 12 (3), 133143,  DOI: 10.1038/nrendo.2015.211
  153. 153
    Pacher, P.; Kunos, G. Modulating the endocannabinoid system in human health and disease – successes and failures. FEBS J. 2013, 280 (9), 19181943,  DOI: 10.1111/febs.12260
  154. 154
    Arul Prakash, S.; Kamlekar, R. K. Function and therapeutic potential of N-acyl amino acids. Chem. Phys. Lipids 2021, 239, 105114  DOI: 10.1016/j.chemphyslip.2021.105114
  155. 155
    Miyazaki, Y.; Oka, S.; Hara-Hotta, H.; Yano, I. Stimulation and inhibition of polymorphonuclear leukocytes phagocytosis by lipoamino acids isolated from Serratia marcescens. FEMS Immunol. Med. Microbiol. 1993, 6 (4), 265271,  DOI: 10.1111/j.1574-695X.1993.tb00338.x
  156. 156
    Cho, W.; York, A. G.; Wang, R.; Wyche, T. P.; Piizzi, G.; Flavell, R. A.; Crawford, J. M. N-Acyl Amides from Neisseria meningitidis and Their Role in Sphingosine Receptor Signaling. Chembiochem 2022, 23 (22), e202200490  DOI: 10.1002/cbic.202200490
  157. 157
    Cohen, L. J.; Esterhazy, D.; Kim, S.-H.; Lemetre, C.; Aguilar, R. R.; Gordon, E. A.; Pickard, A. J.; Cross, J. R.; Emiliano, A. B.; Han, S. M.; Chu, J.; Vila-Farres, X.; Kaplitt, J.; Rogoz, A.; Calle, P. Y.; Hunter, C.; Bitok, J. K.; Brady, S. F. Commensal bacteria make GPCR ligands that mimic human signalling molecules. Nature 2017, 549 (7670), 4853,  DOI: 10.1038/nature23874
  158. 158
    Brady, S. F.; Chao, C. J.; Clardy, J. New Natural Product Families from an Environmental DNA (eDNA) Gene Cluster. J. Am. Chem. Soc. 2002, 124 (34), 99689969,  DOI: 10.1021/ja0268985
  159. 159
    Brady, S. F.; Clardy, J. Long-Chain N-Acyl Amino Acid Antibiotics Isolated from Heterologously Expressed Environmental DNA. J. Am. Chem. Soc. 2000, 122 (51), 1290312904,  DOI: 10.1021/ja002990u
  160. 160
    Brady, S. F.; Chao, C. J.; Clardy, J. Long-chain N-acyltyrosine synthases from environmental DNA. Appl. Environ. Microbiol. 2004, 70 (11), 68656870,  DOI: 10.1128/AEM.70.11.6865-6870.2004
  161. 161
    Peypoux, F.; Laprévote, O.; Pagadoy, M.; Wallach, J. N-Acyl derivatives of Asn, new bacterial N-acyl D-amino acids with surfactant activity. Amino Acids 2004, 26 (2), 209214,  DOI: 10.1007/s00726-003-0056-2
  162. 162
    Geiger, O.; González-Silva, N.; López-Lara, I. M.; Sohlenkamp, C. Amino acid-containing membrane lipids in bacteria. Prog. Lipid Res. 2010, 49 (1), 4660,  DOI: 10.1016/j.plipres.2009.08.002
  163. 163
    Yagi, H.; Corzo, G.; Nakahara, T. N-acyl amino acid biosynthesis in marine bacterium, Deleya marina. Biochim. Biophys. Acta, Gen. Subj. 1997, 1336 (1), 2832,  DOI: 10.1016/S0304-4165(97)00009-3
  164. 164
    Craig, J. W.; Cherry, M. A.; Brady, S. F. Long-chain N-acyl amino acid synthases are linked to the putative PEP-CTERM/exosortase protein-sorting system in Gram-negative bacteria. J. Bacteriol. 2011, 193 (20), 57075715,  DOI: 10.1128/JB.05426-11
  165. 165
    Little, A. E. F.; Robinson, C. J.; Peterson, S. B.; Raffa, K. F.; Handelsman, J. Rules of Engagement: Interspecies Interactions that Regulate Microbial Communities. Annu. Rev. Microbiol. 2008, 62, 375401,  DOI: 10.1146/annurev.micro.030608.101423
  166. 166
    Davies, J.; Spiegelman, G. B.; Yim, G. The world of subinhibitory antibiotic concentrations. Curr. Opin. Microbiol. 2006, 9 (5), 445453,  DOI: 10.1016/j.mib.2006.08.006
  167. 167
    Chevrette, M. G.; Thomas, C. S.; Hurley, A.; Rosario-Meléndez, N.; Sankaran, K.; Tu, Y.; Hall, A.; Magesh, S.; Handelsman, J. Microbiome composition modulates secondary metabolism in a multispecies bacterial community. Proc. Natl. Acad. Sci. U.S.A. 2022, 119 (42), e2212930119  DOI: 10.1073/pnas.2212930119
  168. 168
    Mohimani, H.; Gurevich, A.; Mikheenko, A.; Garg, N.; Nothias, L.-F.; Ninomiya, A.; Takada, K.; Dorrestein, P. C.; Pevzner, P. A. Dereplication of peptidic natural products through database search of mass spectra. Nat. Chem. Biol. 2017, 13 (1), 3037,  DOI: 10.1038/nchembio.2219
  169. 169
    Mohimani, H.; Gurevich, A.; Shlemov, A.; Mikheenko, A.; Korobeynikov, A.; Cao, L.; Shcherbin, E.; Nothias, L.-F.; Dorrestein, P. C.; Pevzner, P. A. Dereplication of microbial metabolites through database search of mass spectra. Nat. Commun. 2018, 9 (1), 4035  DOI: 10.1038/s41467-018-06082-8
  170. 170
    Cao, L.; Guler, M.; Tagirdzhanov, A.; Lee, Y.-Y.; Gurevich, A.; Mohimani, H. MolDiscovery: Learning Mass Spectrometry Fragmentation of Small Molecules. Nat. Commun. 2021, 12 (1), 3718  DOI: 10.1038/s41467-021-23986-0
  171. 171
    Dührkop, K.; Shen, H.; Meusel, M.; Rousu, J.; S, B. Searching Molecular Structure Databases with Tandem Mass Spectra Using CSI:FingerID. Proc. Natl. Acad. Sci. U.S.A. 2015, 112 (41), 1258012585,  DOI: 10.1073/pnas.1509788112
  172. 172
    Pang, Z.; Chong, J.; Zhou, G.; de Lima Morais, D. A.; Chang, L.; Barrette, M.; Gauthier, C.; Jacques, P.-É.; Li, S.; Xia, J. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021, 49 (W1), W388W396,  DOI: 10.1093/nar/gkab382
  173. 173
    Wishart, D. S.; Sayeeda, Z.; Budinski, Z.; Guo, A.; Lee, B. L.; Berjanskii, M.; Rout, M.; Peters, H.; Dizon, R.; Mah, R.; Torres-Calzada, C.; Hiebert-Giesbrecht, M.; Varshavi, D.; Varshavi, D.; Oler, E.; Allen, D.; Cao, X.; Gautam, V.; Maras, A.; Poynton, E. F.; Tavangar, P.; Yang, V.; van Santen, J. A.; Ghosh, R.; Sarma, S.; Knutson, E.; Sullivan, V.; Jystad, A. M.; Renslow, R.; Sumner, L. W.; Linington, R. G.; Cort, J. R. NP-MRD: the Natural Products Magnetic Resonance Database. Nucleic Acids Res. 2022, 50 (D1), D665D677,  DOI: 10.1093/nar/gkab1052

Cited By

Click to copy section linkSection link copied!

This article has not yet been cited by other publications.

Biochemistry

Cite this: Biochemistry 2025, 64, 3, 634–654
Click to copy citationCitation copied!
https://doi.org/10.1021/acs.biochem.4c00706
Published January 14, 2025

Copyright © 2025 The Authors. Published by American Chemical Society. This publication is licensed under

CC-BY 4.0 .

Article Views

1047

Altmetric

-

Citations

-
Learn about these metrics

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

  • Abstract

    Figure 1

    Figure 1. Bacterial isolation and metabolomics workflow. (A) Bacterial isolation from coral mucus, tissue, and the remaining skeleton was performed on six different culture media. Morphologically distinct colonies were isolated and restreaked to ensure purity. (B) Prioritized isolates’ phenotype in mono- and coculture with V. coralliilyticus Cn52-H1. (C) Prioritized strains were cocultured with V. coralliilyticus Cn52-H1, metabolites were extracted using liquid–liquid extraction (LLE), solid phase extraction (SPE), and solid–liquid extraction (SLE). The extracts were analyzed using UPLC-MS and the data was processed for downstream analysis using a suite of cheminformatics tools for compound annotation.

    Figure 2

    Figure 2. Metabolome profiling of bacterial mono- and cocultures. (A) FBMN showcasing a subset of features that were annotated in this study and their representative chemical structures. The amphibactin cluster and a cluster of unknown metabolites detected in coculture with Microbulbifer sp. CNSA0002 and sharing the MS2LDA motif 531 with the amphibactin cluster are highlighted with a green circle. (B) A Venn diagram representation of the number of features detected across different culture conditions. (C) An UpSet plot is used to show the distribution of 76 features unique to cocultures. (D) PCA plot of untargeted metabolomics data acquired on extracts of V. coralliilyticus Cn52-H1 monoculture, Microbulbifer sp. CNSA002 monoculture and their coculture.

    Figure 3

    Figure 3. Amphibactin degradation by Microbulbifer sp. CNSA002. (A) MS2LDA motif 531, annotated as containing N-acetyl-N-hydroxy-ornithine. (B) Spectral comparison of amphibactin F and unknown feature with m/z 617.411 produced only in coculture. (C) MS2 mirror plot of amphibactin F and Fe(III)-amphibactin F. No Fe(III)-bound complex of m/z 617.411 was observed. (D) Amphibactin F, produced by V. coralliilyticus Cn52-H1 is degraded in the presence of Microbulbifer sp. CNSA002 cell-free supernatant producing compound 1, structurally elucidated through NMR (Table S4 and Figures S4–S12). Iron-binding hydroxamate moieties are circled. (E) Boxplots of the relative abundances of amphibactin F and its degradation product in their apo- and complex form in monoculture and coculture. (F) Petri plate showing iron chelating activity of purified compound 1 using O-CAS agar assay.

    Figure 4

    Figure 4. Detection of amphibactins and their degradation products. (A) Boxplots of the relative abundances of amphibactin F (876.529 m/z) and its degradation product (617.412 m/z) in monoculture of V. coralliilyticus Cn52-H1, Microbulbifer sp. CNSA002, their coculture, and Cn52-H1 culture in the presence of cell-free supernatant of CNSA002. (B) Boxplots of relative abundances of degraded amphibactin F in V. coralliilyticus Cn52-H1 cell-free supernatant alone, after boiling, and in the presence of flow through or retentate of an ultrafiltration experiment with either a 3 kDa or 10 kDa membrane. (C) Boxplots of amphibactins and (D) their degradation products in V. coralliilyticus Cn52-H1 monoculture and its coculture with Microbulbifer sp. CNSA002. (E) New amphibactin analogs indirectly identified through their degradation products in Microbulbifer sp. CNSA002 and V. coralliilyticus Cn52-H1 cocultures. The position of double bond was not determined and is putatively placed (shown with dashed line). (F) Boxplots of the relative abundances of amphibactin F and its degradation product in V. coralliilyticus Cn52-H1 monoculture and in coculture with several Microbulbifer sp. strains.

    Figure 5

    Figure 5. Detection of hydroxamate siderophores and ferrisiderophores in the presence of Microbulbifer sp. CNSA002. (A) Boxplot of the relative abundances of desferrioxamine E and ferrioxamine E (601.356 m/z and 654.267 m/z respectively) in Pseudoalteromonas sp. Cnat2–18.1 and Microbulbifer sp. CNSA002 mono- and coculture. (B) Boxplot of the relative abundances of desferrichrome and ferrichrome (688.326 m/z and 741.237 m/z respectively) when supplemented in a Microbulbifer sp. CNSA002 culture and controls. (C) Representative structures of peptidic hydroxamate siderophores: aquachelin, marinobactin, and moanachelin.

    Figure 6

    Figure 6. Boxplots of the relative abundances of bulbiferamide A, prodigiosin and bromotryptamine as well as a representative panel of N-acyl amides, in monoculture and coculture conditions. Asterisks indicate significant differences between the compared groups.

  • References


    This article references 173 other publications.

    1. 1
      Knowlton, N.; Brainard, R. E.; Fisher, R.; Moews, M.; Plaisance, L.; Caley, M. J. Coral Reef Biodiversity; Wiley-Blackwell, 2010.
    2. 2
      Sang, V. T.; Dat, T. T. H.; Vinh, L. B.; Cuong, L. C. V.; Oanh, P. T. T.; Ha, H.; Kim, Y. H.; Anh, H. L. T.; Yang, S. Y. Coral and Coral-Associated Microorganisms: A Prolific Source of Potential Bioactive Natural Products. Mar. Drugs 2019, 17 (8), 468  DOI: 10.3390/md17080468
    3. 3
      McCauley, E. P.; Piña, I. C.; Thompson, A. D.; Bashir, K.; Weinberg, M.; Kurz, S. L.; Crews, P. Highlights of marine natural products having parallel scaffolds found from marine-derived bacteria, sponges, and tunicates. J. Antibiot. 2020, 73 (8), 504525,  DOI: 10.1038/s41429-020-0330-5
    4. 4
      Srinivasan, R.; Kannappan, A.; Shi, C.; Lin, X. Marine Bacterial Secondary Metabolites: A Treasure House for Structurally Unique and Effective Antimicrobial Compounds. Mar. Drugs 2021, 19 (10), 530  DOI: 10.3390/md19100530
    5. 5
      Dinarvand, M.; Spain, M. Identification of Bioactive Compounds from Marine Natural Products and Exploration of Structure-Activity Relationships (SAR). Antibiotics 2021, 10 (3), 337  DOI: 10.3390/antibiotics10030337
    6. 6
      Cappello, E.; Nieri, P. From Life in the Sea to the Clinic: The Marine Drugs Approved and under Clinical Trial. Life 2021, 11 (12), 1390  DOI: 10.3390/life11121390
    7. 7
      Haefner, B. Drugs from the deep: marine natural products as drug candidates. Drug Discovery Today 2003, 8 (12), 536544,  DOI: 10.1016/S1359-6446(03)02713-2
    8. 8
      Knowlton, N.; Rohwer, F. Multispecies Microbial Mutualisms on Coral Reefs: The Host as a Habitat. Am. Nat. 2003, 162 (S4), S51S62,  DOI: 10.1086/378684
    9. 9
      Simon, J.-C.; Marchesi, J. R.; Mougel, C.; Selosse, M.-A. Host-microbiota interactions: from holobiont theory to analysis. Microbiome 2019, 7 (1), 5  DOI: 10.1186/s40168-019-0619-4
    10. 10
      Bewley, C. A.; Holland, N. D.; Faulkner, D. J. Two classes of metabolites from Theonella swinhoei are localized in distinct populations of bacterial symbionts. Experientia 1996, 52 (7), 716722,  DOI: 10.1007/BF01925581
    11. 11
      Piel, J. Metabolites from symbiotic bacteria. Nat. Prod. Rep. 2004, 21 (4), 519538,  DOI: 10.1039/b310175b
    12. 12
      König, G. M.; Kehraus, S.; Seibert, S. F.; Abdel-Lateff, A.; Müller, D. Natural products from marine organisms and their associated microbes. Chembiochem 2006, 7 (2), 229238,  DOI: 10.1002/cbic.200500087
    13. 13
      Vanwonterghem, I.; Webster, N. S. Coral Reef Microorganisms in a Changing Climate. iScience 2020, 23 (4), 100972  DOI: 10.1016/j.isci.2020.100972
    14. 14
      Indraningrat, A. A. G.; Steinert, G.; Becking, L. E.; Mueller, B.; de Goeij, J. M.; Smidt, H.; Sipkema, D. Sponge holobionts shift their prokaryotic communities and antimicrobial activity from shallow to lower mesophotic depths. Antonie van Leeuwenhoek 2022, 115 (10), 12651283,  DOI: 10.1007/s10482-022-01770-4
    15. 15
      Swaminathan, S. D.; Meyer, J. L.; Johnson, M. D.; Paul, V. J.; Bartels, E.; Altieri, A. H. Divergent responses of the coral holobiont to deoxygenation and prior environmental stress. Front. Mar. Sci. 2024, 10, 1301474  DOI: 10.3389/fmars.2023.1301474
    16. 16
      Stévenne, C.; Micha, M.; Plumier, J.-C.; Roberty, S. Corals and Sponges Under the Light of the Holobiont Concept: How Microbiomes Underpin Our Understanding of Marine Ecosystems. Front. Mar. Sci. 2021, 8, 698853  DOI: 10.3389/fmars.2021.698853
    17. 17
      Webster, N. S.; Reusch, T. B. H. Microbial Contributions to the Persistence of Coral Reefs. ISME J. 2017, 11 (10), 21672174,  DOI: 10.1038/ismej.2017.66
    18. 18
      Reshef, L.; Koren, O.; Loya, Y.; Zilber-Rosenberg, I.; Rosenberg, E. The coral probiotic hypothesis. Environ. Microbiol. 2006, 8 (12), 20682073,  DOI: 10.1111/j.1462-2920.2006.01148.x
    19. 19
      Eddy, T. D.; Lam, V. W. Y.; Reygondeau, G.; Cisneros-Montemayor, A. M.; Greer, K.; Palomares, M. L. D.; Bruno, J. F.; Ota, Y.; Cheung, W. W. L. Global decline in capacity of coral reefs to provide ecosystem services. One Earth 2021, 4 (9), 12781285,  DOI: 10.1016/j.oneear.2021.08.016
    20. 20
      Humanes, A.; Lachs, L.; Beauchamp, E.; Bukurou, L.; Buzzoni, D.; Bythell, J.; Craggs, J. R. K.; de la Torre Cerro, R.; Edwards, A. J.; Golbuu, Y.; Martinez, H. M.; Palmowski, P.; van der Steeg, E.; Sweet, M.; Ward, A.; Wilson, A. J.; Guest, J. R. Selective breeding enhances coral heat tolerance to marine heatwaves. Nat. Commun. 2024, 15 (1), 8703  DOI: 10.1038/s41467-024-52895-1
    21. 21
      Ushijima, B.; Gunasekera, S. P.; Meyer, J. L.; Tittl, J.; Pitts, K. A.; Thompson, S.; Sneed, J. M.; Ding, Y.; Chen, M.; Jay Houk, L.; Aeby, G. S.; Häse, C. C.; Paul, V. J. Chemical and genomic characterization of a potential probiotic treatment for stony coral tissue loss disease. Commun. Biol. 2023, 6 (1), 248  DOI: 10.1038/s42003-023-04590-y
    22. 22
      Peixoto, R. S.; Rosado, P. M.; de Assis Leite, D. C.; Rosado, A. S.; Bourne, D. G. Beneficial Microorganisms for Corals (BMC): Proposed Mechanisms for Coral Health and Resilience. Front. Microbiol. 2017, 8, 341  DOI: 10.3389/fmicb.2017.00341
    23. 23
      Deutsch, J. M.; Mandelare-Ruiz, P.; Yang, Y.; Foster, G.; Routhu, A.; Houk, J.; De La Flor, Y. T.; Ushijima, B.; Meyer, J. L.; Paul, V. J.; Garg, N. Metabolomics Approaches to Dereplicate Natural Products from Coral-Derived Bioactive Bacteria. J. Nat. Prod. 2022, 85 (3), 462478,  DOI: 10.1021/acs.jnatprod.1c01110
    24. 24
      Sweet, M.; Villela, H.; Keller-Costa, T.; Costa, R.; Romano, S.; Bourne, D. G.; Cárdenas, A.; Huggett, M. J.; Kerwin, A. H.; Kuek, F.; Medina, M.; Meyer, J. L.; Müller, M.; Pollock, F. J.; Rappé, M. S.; Sere, M.; Sharp, K. H.; Voolstra, C. R.; Zaccardi, N.; Ziegler, M.; Peixoto, R.; Bouskill, N.; Speare, L.; Shore, A. Insights into the Cultured Bacterial Fraction of Corals. mSystems 2021, 6 (3), e0124920  DOI: 10.1128/mSystems.01249-20
    25. 25
      Ziegler, M.; Seneca, F. O.; Yum, L. K.; Palumbi, S. R.; Voolstra, C. R. Bacterial community dynamics are linked to patterns of coral heat tolerance. Nat. Commun. 2017, 8, 14213  DOI: 10.1038/ncomms14213
    26. 26
      Flórez, L. V.; Biedermann, P. H. W.; Engl, T.; Kaltenpoth, M. Defensive symbioses of animals with prokaryotic and eukaryotic microorganisms. Nat. Prod. Rep. 2015, 32 (7), 904936,  DOI: 10.1039/C5NP00010F
    27. 27
      Uria, A.; Piel, J. Cultivation-independent approaches to investigate the chemistry of marine symbiotic bacteria. Phytochem. Rev. 2009, 8 (2), 401414,  DOI: 10.1007/s11101-009-9127-7
    28. 28
      Ritchie, K. B. Regulation of Microbial Populations by Coral Surface Mucus and Mucus-Associated Bacteria. Mar. Ecol.: Prog. Ser. 2006, 322, 114,  DOI: 10.3354/meps322001
    29. 29
      Raina, J.-B.; Tapiolas, D.; Motti, C. A.; Foret, S.; Seemann, T.; Tebben, J.; Willis, B. L.; Bourne, D. G. Isolation of an antimicrobial compound produced by bacteria associated with reef-building corals. PeerJ 2016, 4, e2275  DOI: 10.7717/peerj.2275
    30. 30
      Kvennefors, E. C. E.; Sampayo, E.; Kerr, C.; Vieira, G.; Roff, G.; Barnes, A. C. Regulation of Bacterial Communities Through Antimicrobial Activity by the Coral Holobiont. Microb. Ecol. 2012, 63 (3), 605618,  DOI: 10.1007/s00248-011-9946-0
    31. 31
      Delgadillo-Ordoñez, N.; Garcias-Bonet, N.; Raimundo, I.; García, F. C.; Villela, H.; Osman, E. O.; Santoro, E. P.; Curdia, J.; Rosado, J. G. D.; Cardoso, P.; Alsaggaf, A.; Barno, A.; Antony, C. P.; Bocanegra, C.; Berumen, M. L.; Voolstra, C. R.; Benzoni, F.; Carvalho, S.; Peixoto, R. S. Probiotics reshape the coral microbiome in situ without detectable off-target effects in the surrounding environment. Commun. Biol. 2024, 7 (1), 434  DOI: 10.1038/s42003-024-06135-3
    32. 32
      Papke, E.; Carreiro, A.; Dennison, C.; Deutsch, J. M.; Isma, L. M.; Meiling, S. S.; Rossin, A. M.; Baker, A. C.; Brandt, M. E.; Garg, N.; Holstein, D. M.; Traylor-Knowles, N.; Voss, J. D.; Ushijima, B. Stony coral tissue loss disease: a review of emergence, impacts, etiology, diagnostics, and intervention. Front. Mar. Sci. 2024, 10, 1321271  DOI: 10.3389/fmars.2023.1321271
    33. 33
      Vidal-Dupiol, J.; Ladrière, O.; Meistertzheim, A. L.; Fouré, L.; Adjeroud, M.; Mitta, G. Physiological responses of the scleractinian coral Pocillopora damicornis to bacterial stress from Vibrio coralliilyticus. J. Exp. Biol. 2011, 214 (Pt 9), 15331545,  DOI: 10.1242/jeb.053165
    34. 34
      Roder, C.; Arif, C.; Bayer, T.; Aranda, M.; Daniels, C.; Shibl, A.; Chavanich, S.; Voolstra, C. R. Bacterial profiling of White Plague Disease in a comparative coral species framework. Isme J. 2014, 8 (1), 3139,  DOI: 10.1038/ismej.2013.127
    35. 35
      Ben-Haim, Y.; Zicherman-Keren, M.; Rosenberg, E. Temperature-regulated bleaching and lysis of the coral Pocillopora damicornis by the novel pathogen Vibrio coralliilyticus. Appl. Environ. Microbiol. 2003, 69 (7), 42364242,  DOI: 10.1128/AEM.69.7.4236-4242.2003
    36. 36
      Estes, R. M.; Friedman, C. S.; Elston, R. A.; Herwig, R. P. Pathogenicity testing of shellfish hatchery bacterial isolates on Pacific oyster Crassostrea gigas larvae. Dis. Aquat. Org. 2004, 58 (2–3), 223230,  DOI: 10.3354/dao058223
    37. 37
      Manchanayake, T.; Salleh, A.; Amal, M. N. A.; Yasin, I. S. M.; Zamri-Saad, M. Pathology and pathogenesis of Vibrio infection in fish: A review. Aquacult. Rep. 2023, 28, 101459  DOI: 10.1016/j.aqrep.2022.101459
    38. 38
      Vizcaino, M. I.; Johnson, W. R.; Kimes, N. E.; Williams, K.; Torralba, M.; Nelson, K. E.; Smith, G. W.; Weil, E.; Moeller, P. D.; Morris, P. J. Antimicrobial resistance of the coral pathogen Vibrio coralliilyticus and Caribbean sister phylotypes isolated from a diseased octocoral. Microb. Ecol. 2010, 59 (4), 646657,  DOI: 10.1007/s00248-010-9644-3
    39. 39
      Ushijima, B.; Meyer, J. L.; Thompson, S.; Pitts, K.; Marusich, M. F.; Tittl, J.; Weatherup, E.; Reu, J.; Wetzell, R.; Aeby, G. S.; Häse, C. C.; Paul, V. J. Disease Diagnostics and Potential Coinfections by Vibrio coralliilyticus During an Ongoing Coral Disease Outbreak in Florida. Front. Microbiol. 2020, 11, 569354  DOI: 10.3389/fmicb.2020.569354
    40. 40
      Heinz, J. M.; Lu, J.; Huebner, L. K.; Salzberg, S. L.; Sommer, M.; Rosales, S. M. Novel metagenomics analysis of stony coral tissue loss disease bioRxiv: The Preprint Server for Biology 2024  DOI: 10.1101/2024.01.02.573916 .
    41. 41
      Meyer, J. L.; Castellanos-Gell, J.; Aeby, G. S.; Häse, C. C.; Ushijima, B.; Paul, V. J. Microbial Community Shifts Associated With the Ongoing Stony Coral Tissue Loss Disease Outbreak on the Florida Reef Tract. Front. Microbiol. 2019, 10, 2244  DOI: 10.3389/fmicb.2019.02244
    42. 42
      Shilling, E. N.; Combs, I. R.; Voss, J. D. Assessing the effectiveness of two intervention methods for stony coral tissue loss disease on Montastraea cavernosa. Sci. Rep. 2021, 11 (1), 8566  DOI: 10.1038/s41598-021-86926-4
    43. 43
      Studivan, M. S.; Eckert, R. J.; Shilling, E.; Soderberg, N.; Enochs, I. C.; Voss, J. D. Stony coral tissue loss disease intervention with amoxicillin leads to a reversal of disease-modulated gene expression pathways. Mol. Ecol. 2023, 32 (19), 53945413,  DOI: 10.1111/mec.17110
    44. 44
      Rubio-Portillo, E.; Santos, F.; Martínez-García, M.; de Los Ríos, A.; Ascaso, C.; Souza-Egipsy, V.; Ramos-Esplá, A. A.; Anton, J. Structure and temporal dynamics of the bacterial communities associated to microhabitats of the coral Oculina patagonica. Environ. Microbiol. 2016, 18 (12), 45644578,  DOI: 10.1111/1462-2920.13548
    45. 45
      Sunagawa, S.; Coelho, L. P.; Chaffron, S.; Kultima, J. R.; Labadie, K.; Salazar, G.; Djahanschiri, B.; Zeller, G.; Mende, D. R.; Alberti, A.; Cornejo-Castillo, F. M.; Costea, P. I.; Cruaud, C.; d’Ovidio, F.; Engelen, S.; Ferrera, I.; Gasol, J. M.; Guidi, L.; Hildebrand, F.; Kokoszka, F.; Lepoivre, C.; Lima-Mendez, G.; Poulain, J.; Poulos, B. T.; Royo-Llonch, M.; Sarmento, H.; Vieira-Silva, S.; Dimier, C.; Picheral, M.; Searson, S.; Kandels-Lewis, S.; Oceans, T.; Bowler, C.; de Vargas, C.; Gorsky, G.; Grimsley, N.; Hingamp, P.; Iudicone, D.; Jaillon, O.; Not, F.; Ogata, H.; Pesant, S.; Speich, S.; Stemmann, L.; Sullivan, M. B.; Weissenbach, J.; Wincker, P.; Karsenti, E.; Raes, J.; Acinas, S. G.; Bork, P.; Boss, E.; Bowler, C.; Follows, M.; Karp-Boss, L.; Krzic, U.; Reynaud, E. G.; Sardet, C.; Sieracki, M.; Velayoudon, D. Structure and function of the global ocean microbiome. Science 2015, 348 (6237), 1261359  DOI: 10.1126/science.1261359
    46. 46
      Su, H.; Xiao, Z.; Yu, K.; Huang, Q.; Wang, G.; Wang, Y.; Liang, J.; Huang, W.; Huang, X.; Wei, F.; Chen, B. Diversity of cultivable protease-producing bacteria and their extracellular proteases associated to scleractinian corals. PeerJ 2020, 8, e9055  DOI: 10.7717/peerj.9055
    47. 47
      Wei, Y.; Bu, J.; Long, H.; Zhang, X.; Cai, X.; Huang, A.; Ren, W.; Xie, Z. Community Structure of Protease-Producing Bacteria Cultivated From Aquaculture Systems: Potential Impact of a Tropical Environment. Front. Microbiol. 2021, 12, 638129  DOI: 10.3389/fmicb.2021.638129
    48. 48
      Zhou, M.-Y.; Wang, G.-L.; Li, D.; Zhao, D.-L.; Qin, Q.-L.; Chen, X.-L.; Chen, B.; Zhou, B.-C.; Zhang, X.-Y.; Zhang, Y.-Z. Diversity of Both the Cultivable Protease-Producing Bacteria and Bacterial Extracellular Proteases in the Coastal Sediments of King George Island, Antarctica. PLoS One 2013, 8 (11), e79668  DOI: 10.1371/journal.pone.0079668
    49. 49
      Cristóbal, H. A.; López, M. A.; Kothe, E.; Abate, C. M. Diversity of protease-producing marine bacteria from sub-antarctic environments. J. Basic Microbiol. 2011, 51 (6), 590600,  DOI: 10.1002/jobm.201000413
    50. 50
      Zhang, J.; Chen, M.; Huang, J.; Guo, X.; Zhang, Y.; Liu, D.; Wu, R.; He, H.; Wang, J. Diversity of the microbial community and cultivable protease-producing bacteria in the sediments of the Bohai Sea, Yellow Sea and South China Sea. PLoS One 2019, 14 (4), e0215328  DOI: 10.1371/journal.pone.0215328
    51. 51
      Paulsen, S. S.; Strube, M. L.; Bech, P. K.; Gram, L.; Sonnenschein, E. C. Marine Chitinolytic Pseudoalteromonas Represents an Untapped Reservoir of Bioactive Potential. mSystems 2019, 4 (4), e00060-19  DOI: 10.1128/mSystems.00060-19
    52. 52
      Cimermancic, P.; Medema, M. H.; Claesen, J.; Kurita, K.; Brown, L. C. W.; Mavrommatis, K.; Pati, A.; Godfrey, P. A.; Koehrsen, M.; Clardy, J.; Birren, B. W.; Takano, E.; Sali, A.; Linington, R. G.; Fischbach, M. A. Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell 2014, 158 (2), 412421,  DOI: 10.1016/j.cell.2014.06.034
    53. 53
      Buijs, Y.; Bech, P. K.; Vazquez-Albacete, D.; Bentzon-Tilia, M.; Sonnenschein, E. C.; Gram, L.; Zhang, S.-D. Marine Proteobacteria as a source of natural products: advances in molecular tools and strategies. Nat. Prod. Rep. 2019, 36 (9), 13331350,  DOI: 10.1039/C9NP00020H
    54. 54
      Baba, A.; Miyazaki, M.; Nagahama, T.; Nogi, Y. Microbulbifer chitinilyticus sp. nov. and Microbulbifer okinawensis sp. nov., chitin-degrading bacteria isolated from mangrove forests. Int. J. Syst. Evol. Microbiol. 2011, 61 (Pt 9), 22152220,  DOI: 10.1099/ijs.0.024158-0
    55. 55
      Miyazaki, M.; Nogi, Y.; Ohta, Y.; Hatada, Y.; Fujiwara, Y.; Ito, S.; Horikoshi, K. Microbulbifer agarilyticus sp. nov. and Microbulbifer thermotolerans sp. nov., agar-degrading bacteria isolated from deep-sea sediment. Int. J. Syst. Evol. Microbiol. 2008, 58, 11281133,  DOI: 10.1099/ijs.0.65507-0
    56. 56
      Vashist, P.; Nogi, Y.; Ghadi, S. C.; Verma, P.; Shouche, Y. S. Microbulbifer mangrovi sp. nov., a polysaccharide-degrading bacterium isolated from an Indian mangrove. Int. J. Syst. Evol. Microbiol. 2013, 63, 25322537,  DOI: 10.1099/ijs.0.042978-0
    57. 57
      González, J. M.; Mayer, F.; Moran, M. A.; Hodson, R. E.; Whitman, W. B. Microbulbifer hydrolyticus gen. nov., sp. nov., and Marinobacterium georgiense gen. nov., sp. nov., two marine bacteria from a lignin-rich pulp mill waste enrichment community. Int. J. Syst. Bacteriol. 1997, 47 (2), 369376,  DOI: 10.1099/00207713-47-2-369
    58. 58
      Lee, Y. S. Isolation and Characterization of a Novel Cold-Adapted Esterase, MtEst45, from Microbulbifer thermotolerans DAU221. Front. Microbiol. 2016, 7, 218  DOI: 10.3389/fmicb.2016.00218
    59. 59
      Jayanetti, D. R.; Braun, D. R.; Barns, K. J.; Rajski, S. R.; Bugni, T. S. Bulbiferates A and B: Antibacterial Acetamidohydroxybenzoates from a Marine Proteobacterium, Microbulbifer sp. J. Nat. Prod. 2019, 82 (7), 19301934,  DOI: 10.1021/acs.jnatprod.9b00312
    60. 60
      Lu, S.; Zhang, Z.; Sharma, A. R.; Nakajima-Shimada, J.; Harunari, E.; Oku, N.; Trianto, A.; Igarashi, Y. Bulbiferamide, an Antitrypanosomal Hexapeptide Cyclized via an N-Acylindole Linkage from a Marine Obligate Microbulbifer. J. Nat. Prod. 2023, 86 (4), 10811086,  DOI: 10.1021/acs.jnatprod.2c01083
    61. 61
      Zhong, W.; Deutsch, J. M.; Yi, D.; Abrahamse, N. H.; Mohanty, I.; Moore, S. G.; McShan, A. C.; Garg, N.; Agarwal, V. Discovery and Biosynthesis of Ureidopeptide Natural Products Macrocyclized via Indole N-acylation in Marine Microbulbifer spp. Bacteria. ChemBioChem 2023, 24 (12), e202300190  DOI: 10.1002/cbic.202300190
    62. 62
      Zhong, W.; Aiosa, N.; Deutsch, J. M.; Garg, N.; Agarwal, V. Pseudobulbiferamides: Plasmid-Encoded Ureidopeptide Natural Products with Biosynthetic Gene Clusters Shared Among Marine Bacteria of Different Genera. J. Nat. Prod. 2023, 86 (10), 24142420,  DOI: 10.1021/acs.jnatprod.3c00595
    63. 63
      Zhong, W.; Agarwal, V. Polymer degrading marine Microbulbifer bacteria: an un(der)utilized source of chemical and biocatalytic novelty. Beilstein J. Org. Chem. 2024, 20, 16351651,  DOI: 10.3762/bjoc.20.146
    64. 64
      Mawji, E.; Gledhill, M.; Milton, J. A.; Tarran, G. A.; Ussher, S.; Thompson, A.; Wolff, G. A.; Worsfold, P. J.; Achterberg, E. P. Hydroxamate siderophores: occurrence and importance in the Atlantic Ocean. Environ. Sci. Technol. 2008, 42 (23), 86758680,  DOI: 10.1021/es801884r
    65. 65
      Boiteau, R. M.; Mende, D. R.; Hawco, N. J.; McIlvin, M. R.; Fitzsimmons, J. N.; Saito, M. A.; Sedwick, P. N.; DeLong, E. F.; Repeta, D. J. Siderophore-Based Microbial Adaptations to Iron Scarcity Across the Eastern Pacific Ocean. Proc. Natl. Acad. Sci. U.S.A. 2016, 113 (50), 1423714242,  DOI: 10.1073/pnas.1608594113
    66. 66
      Deutsch, J. M.; Green, M. O.; Akavaram, P.; Davis, A. C.; Diskalkar, S. S.; Du Plessis, I. A.; Fallon, H. A.; Grason, E. M.; Kauf, E. G.; Kim, Z. M.; Miller, J. R.; Neal, A. L.; Riera, T.; Stroeva, S.-E.; Tran, J.; Tran, V.; Coronado, A. V.; Coronado, V. V.; Wall, B. T.; Yang, Cm.; Mohanty, I.; Abrahamse, N. H.; Freeman, C. J.; Easson, C. G.; Fiore, C. L.; Onstine, A. E.; Djeddar, N.; Biliya, S.; Bryksin, A. V.; Garg, N.; Agarwal, V. Limited Metabolomic Overlap between Commensal Bacteria and Marine Sponge Holobionts Revealed by Large Scale Culturing and Mass Spectrometry-Based Metabolomics: An Undergraduate Laboratory Pedagogical Effort at Georgia Tech. Mar. Drugs 2023, 21 (1), 53  DOI: 10.3390/md21010053
    67. 67
      Buijs, Y.; Isbrandt, T.; Zhang, S.-D.; Larsen, T. O.; Gram, L. The Antibiotic Andrimid Produced by Vibrio coralliilyticus Increases Expression of Biosynthetic Gene Clusters and Antibiotic Production in Photobacterium galatheae. Front. Microbiol. 2020, 11, 622055  DOI: 10.3389/fmicb.2020.622055
    68. 68
      Pluskal, T.; Castillo, S.; Villar-Briones, A.; Orešič, M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinf. 2010, 11 (1), 395  DOI: 10.1186/1471-2105-11-395
    69. 69
      Wang, M.; Carver, J. J.; Phelan, V. V.; Sanchez, L. M.; Garg, N.; Peng, Y.; Nguyen, D. D.; Watrous, J.; Kapono, C. A.; Luzzatto-Knaan, T.; Porto, C.; Bouslimani, A.; Melnik, A. V.; Meehan, M. J.; Liu, W.-T.; Crüsemann, M.; Boudreau, P. D.; Esquenazi, E.; Sandoval-Calderón, M.; Kersten, R. D.; Pace, L. A.; Quinn, R. A.; Duncan, K. R.; Hsu, C.-C.; Floros, D. J.; Gavilan, R. G.; Kleigrewe, K.; Northen, T.; Dutton, R. J.; Parrot, D.; Carlson, E. E.; Aigle, B.; Michelsen, C. F.; Jelsbak, L.; Sohlenkamp, C.; Pevzner, P.; Edlund, A.; McLean, J.; Piel, J.; Murphy, B. T.; Gerwick, L.; Liaw, C.-C.; Yang, Y.-L.; Humpf, H.-U.; Maansson, M.; Keyzers, R. A.; Sims, A. C.; Johnson, A. R.; Sidebottom, A. M.; Sedio, B. E.; Klitgaard, A.; Larson, C. B.; Boya P, C. A.; Torres-Mendoza, D.; Gonzalez, D. J.; Silva, D. B.; Marques, L. M.; Demarque, D. P.; Pociute, E.; O’Neill, E. C.; Briand, E.; Helfrich, E. J. N.; Granatosky, E. A.; Glukhov, E.; Ryffel, F.; Houson, H.; Mohimani, H.; Kharbush, J. J.; Zeng, Y.; Vorholt, J. A.; Kurita, K. L.; Charusanti, P.; McPhail, K. L.; Nielsen, K. F.; Vuong, L.; Elfeki, M.; Traxler, M. F.; Engene, N.; Koyama, N.; Vining, O. B.; Baric, R.; Silva, R. R.; Mascuch, S. J.; Tomasi, S.; Jenkins, S.; Macherla, V.; Hoffman, T.; Agarwal, V.; Williams, P. G.; Dai, J.; Neupane, R.; Gurr, J.; Rodríguez, A. M. C.; Lamsa, A.; Zhang, C.; Dorrestein, K.; Duggan, B. M.; Almaliti, J.; Allard, P.-M.; Phapale, P.; Nothias, L.-F.; Alexandrov, T.; Litaudon, M.; Wolfender, J.-L.; Kyle, J. E.; Metz, T. O.; Peryea, T.; Nguyen, D.-T.; VanLeer, D.; Shinn, P.; Jadhav, A.; Müller, R.; Waters, K. M.; Shi, W.; Liu, X.; Zhang, L.; Knight, R.; Jensen, P. R.; Palsson, B. Ø.; Pogliano, K.; Linington, R. G.; Gutiérrez, M.; Lopes, N. P.; Gerwick, W. H.; Moore, B. S.; Dorrestein, P. C.; Bandeira, N. Sharing and community curation of mass spectrometry data with Global Natural Products Social Molecular Networking. Nat. Biotechnol. 2016, 34 (8), 828837,  DOI: 10.1038/nbt.3597
    70. 70
      Shannon, P.; Markie, A.; Ozier, O.; Baliga, N. S.; Wang, J. T.; Ramage, D.; Amin, N.; Schwikowski, B.; Ideker, T. Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks. Genome Res. 2003, 13, 24982504,  DOI: 10.1101/gr.1239303
    71. 71
      Khan, A.; Mathelier, A. Intervene: a tool for intersection and visualization of multiple gene or genomic region sets. BMC Bioinf. 2017, 18 (1), 287  DOI: 10.1186/s12859-017-1708-7
    72. 72
      Dührkop, K.; Fleischauer, M.; Ludwig, M.; Aksenov, A. A.; Melnik, A. V. SIRIUS 4: A Rapid Tool for Turning Tandem Mass Spectra into Metabolite Structure Information. Nat. Methods 2019, 16, 299302,  DOI: 10.1038/s41592-019-0344-8
    73. 73
      Dührkop, K.; Nothias, L.-F.; Fleischauer, M.; Reher, R.; Ludwig, M.; Hoffmann, M. A.; Petras, D.; Gerwick, W. H.; Rousu, J.; Dorrestein, P. C.; Böcker, S. Systematic Classification of Unknown Metabolites Using High-Resolution Fragmentation Mass Spectra. Nat. Biotechnol. 2021, 39, 462471,  DOI: 10.1038/s41587-020-0740-8
    74. 74
      van der Hooft, J. J. J.; Wandy, J.; Barrett, M. P.; Burgess, K. E. V.; Rogers, S. Topic modeling for untargeted substructure exploration in metabolomics. Proc. Natl. Acad. Sci. U.S.A. 2016, 113 (48), 1373813743,  DOI: 10.1073/pnas.1608041113
    75. 75
      van Santen, J. A.; Jacob, G.; Singh, A. L.; Aniebok, V.; Balunas, M. J.; Bunsko, D.; Neto, F. C.; Castaño-Espriu, L.; Chang, C.; Clark, T. N.; Cleary Little, J. L.; Delgadillo, D. A.; Dorrestein, P. C.; Duncan, K. R.; Egan, J. M.; Galey, M. M.; Haeckl, F. P. J.; Hua, A.; Hughes, A. H.; Iskakova, D.; Khadilkar, A.; Lee, J.-H.; Lee, S.; LeGrow, N.; Liu, D. Y.; Macho, J. M.; McCaughey, C. S.; Medema, M. H.; Neupane, R. P.; O’Donnell, T. J.; Paula, J. S.; Sanchez, L. M.; Shaikh, A. F.; Soldatou, S.; Terlouw, B. R.; Tran, T. A.; Valentine, M.; van der Hooft, J. J. J.; Vo, D. A.; Wang, M.; Wilson, D.; Zink, K. E.; Linington, R. G. The Natural Products Atlas: An Open Access Knowledge Base for Microbial Natural Products Discovery. ACS Cent. Sci. 2019, 5 (11), 18241833,  DOI: 10.1021/acscentsci.9b00806
    76. 76
      MarinLit. A Database of the Marine Natural Products Literature, Royal Society of Chemistry http://pubs.rsc.org/marinlit/. (accessed January 20, 2023).
    77. 77
      Al Shaer, D.; Al Musaimi, O.; de la Torre, B. G.; Albericio, F. Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens. Eur. J. Med. Chem. 2020, 208, 112791  DOI: 10.1016/j.ejmech.2020.112791
    78. 78
      Martinez, J. S.; Carter-Franklin, J. N.; Mann, E. L.; Martin, J. D.; Haygood, M. G.; Butler, A. Structure and membrane affinity of a suite of amphiphilic siderophores produced by a marine bacterium. Proc. Natl. Acad. Sci. U.S.A. 2003, 100 (7), 37543759,  DOI: 10.1073/pnas.0637444100
    79. 79
      Walker, L. R.; Tfaily, M. M.; Shaw, J. B.; Hess, N. J.; Paša-Tolić, L.; Koppenaal, D. W. Unambiguous identification and discovery of bacterial siderophores by direct injection 21 T Fourier transform ion cyclotron resonance mass spectrometry. Metallomics 2017, 9 (1), 8292,  DOI: 10.1039/C6MT00201C
    80. 80
      Pérez-Miranda, S.; Cabirol, N.; George-Téllez, R.; Zamudio-Rivera, L. S.; Fernández, F. J. O-CAS, a fast and universal method for siderophore detection. J. Microbiol. Methods 2007, 70 (1), 127131,  DOI: 10.1016/j.mimet.2007.03.023
    81. 81
      Raines, D. J.; Sanderson, T. J.; Wilde, E. J.; Duhme-Klair, A. K. Siderophores. In Reference Module in Chemistry, Molecular Sciences and Chemical Engineering; Elsevier, 2015.
    82. 82
      Hou, Z.; Raymond, K. N.; O’Sulliva, B.; Esker, T. W.; Nishio, T. A Preorganized Siderophore: Thermodynamic and Structural Characterization of Alcaligin and Bisucaberin, Microbial Macrocyclic Dihydroxamate Chelating Agents1. Inorg. Chem. 1998, 37 (26), 66306637,  DOI: 10.1021/ic9810182
    83. 83
      Harris, W. R.; Carrano, C. J.; Raymond, K. N. Coordination chemistry of microbial iron transport compounds. 16. Isolation, characterization, and formation constants of ferric aerobactin. J. Am. Chem. Soc. 1979, 101 (10), 27222727,  DOI: 10.1021/ja00504a038
    84. 84
      Ito, T.; Neilands, J. B. Products of “Low-iron Fermentation” with Bacillus subilis: Isolation, Characterization and Synthesis of 2,3-Dihydroxybenzoylglycine1,2. J. Am. Chem. Soc. 1958, 80 (17), 46454647,  DOI: 10.1021/ja01550a058
    85. 85
      Barghouthi, S.; Young, R.; Olson, M. O.; Arceneaux, J. E.; Clem, L. W.; Byers, B. R. Amonabactin, a novel tryptophan- or phenylalanine-containing phenolate siderophore in Aeromonas hydrophila. J. Bacteriol. 1989, 171 (4), 18111816,  DOI: 10.1128/jb.171.4.1811-1816.1989
    86. 86
      Atkin, C. L.; Neilands, J. B. Rhodotorulic acid, a diketopiperazine dihydroxamic acid with growth-factor activity. I. Isolation and characterization. Biochemistry 1968, 7 (10), 37343739,  DOI: 10.1021/bi00850a054
    87. 87
      Spasojević, I.; Boukhalfa, H.; Stevens, R. D.; Crumbliss, A. L. Aqueous Solution Speciation of Fe(III) Complexes with Dihydroxamate Siderophores Alcaligin and Rhodotorulic Acid and Synthetic Analogues Using Electrospray Ionization Mass Spectrometry. Inorg. Chem. 2001, 40 (1), 4958,  DOI: 10.1021/ic991390x
    88. 88
      Xu, G.; Martinez, J. S.; Groves, J. T.; Butler, A. Membrane Affinity of the Amphiphilic Marinobactin Siderophores. J. Am. Chem. Soc. 2002, 124 (45), 1340813415,  DOI: 10.1021/ja026768w
    89. 89
      Harrington, J. M.; Crumbliss, A. L. The redox hypothesis in siderophore-mediated iron uptake. BioMetals 2009, 22 (4), 679689,  DOI: 10.1007/s10534-009-9233-4
    90. 90
      Schalk, I. J.; Guillon, L. Fate of ferrisiderophores after import across bacterial outer membranes: different iron release strategies are observed in the cytoplasm or periplasm depending on the siderophore pathways. Amino Acids 2013, 44 (5), 12671277,  DOI: 10.1007/s00726-013-1468-2
    91. 91
      Miethke, M.; Marahiel, M. A. Siderophore-Based Iron Acquisition and Pathogen Control. Microbiol. Mol. Biol. Rev. 2007, 71 (3), 413451,  DOI: 10.1128/MMBR.00012-07